Scientific Articles

To search for articles, please use the "search" or "find" feature on your internet browser. All articles are organized by keywords like toxic chemical and associated disease. To locate the article, print the citation and take it to your local library or contact katherine.southwick@mssm.edu.

Air Pollutants

1. Claudio L, Torres T, Sanjurjo E, Sherman L, Landrigan PJ. Environmental health sciences education-A tool for achieving environmental equity and protecting our children. Environ Health Perspect 1998; 106:849-855.

2. Golden AL, Berkowitz GS, Wolff MS, Godbold J, Afilaka A, Chillrud S, Bopp R, Simpson H, Landrigan PJ. Body burdens of persistent pollutants in Hudson River anglers. Environ Res 2005.

3. Landrigan PJ, Goldstein EA. Smoke gets in our eyes. New York Newsday 62.

4. Landrigan PJ. Indoor air quality: A doctor's viewpoint. The CHEC Report 2003(9).

5. Asthma in American Children. Congressional Staff Briefing: Asthma and the Environment: Protecting our Children [Landrigan PJ]. 1-4 (1999).

6. Landrigan PJ. Lead levels, home dust, and proximity to lead smelters (letter). Pediatrics 1996; 97:603-604.

7. Landrigan PJ. The incompletely studied hazards of waste incineration. Am J Ind Med 1989; 15:243-244.

8. Landrigan PJ. Epidemiologic assessment of lead absorption associated with incineration of municipal waste. Proceedings of annual meeting of american public health association; November 13-17 1988.

9. Landrigan PJ. Occupational and community exposures to toxic metals - lead, cadmium, mercury and arsenic. Western J Med 1982; 137: 532-539.

10. Landrigan PJ. Overview of industrial chemical exposures. Environ Res 1993; 61:157-163.

11. Landrigan PJ, Baker EL. Exposure of children to heavy metals from smelters: Epidemiology and toxic consequences. Environ Res 1981; 25:204-244.

12. Landrigan PJ, Bridbord K. Additional exposure routes. In: Dahlem Konferenzen, editor. Changing Metal Cycles and Health. Berlin: Springer-Verlag; 1984.

13. Landrigan PJ, Halper LA, Silbergeld EK. Toxic air pollution across a state line: Implications for the siting of resource recovery facilities.  J Public Health Policy 1989; 10:309-323.

14. Landrigan PJ, Gross RL. Chemical wastes - illegal hazards and legal remedies. Am J Public Health 1981; 71:985-987.

15. Levin SM, Landrigan PJ. Tollbooth syndrome. New York Times.

16. Miller RW, Brent RL, Brown AK, Finberg L, Frantz C, Goldbloom VC, Heavenrich RM, Peebles TC, Stevenson JL, Jr., Falk H, Knelson JH, Landrigan PJ, Rogan, WJ. American Academy of Pediatrics. Committee on Environmental Hazards. National Standard for Airborne Lead. Peds 1978; 62:1070-1071.

17. Morabia A, Amstislavski PN, Mirer FE, Amstislavski TM, Eisl H, Wolff MS, Markowitz SB. Air pollution and activity during transportation by car, subway, and walking. Am J Prev Med 2009; 37:72-77.

18. Needleman HL, Jackson RJ, Landrigan PJ, Lipsett M. Committee on Environmental Health, American Academy of Pediatrics: Ambient air pollution: Respiratory hazards to children. Pediatrics 1993; 91:1210-1213.

19. Roy A, Sheffield PE, Wong K, Trasande L. Economic consequences of subchronic air pollutant exposure for pediatric asthma hospitalizations. Pediatric Academic Societies Meeting; May 2010.

20. Trasande L, Thurston GD. The role of air pollution in asthma and other pediatric morbidities. J Allergy Clin Immunol 2005; 115(4):689-699.

Arsenic

1. Kreiss K, Zack MM, Landrigan PJ, Feldman RG, Niles CA, Chirico-Post J, Sax DS, Boyd MH, Cox DH. Neurologic evaluation of a population exposed to arsenic in Alaskan well water. Am J Public Health 1983; 38:117-121.

2. Landrigan PJ. Developmental neurotoxicity of industrial chemicals and pediatric bipolar disorder: A call to research. In: S. Olfman, editor. Bipolar Children. Praeger Publishers; 2007.

3. Landrigan PJ. Arsenic. In: Rom WN, editor. Environmental and Occupational Medicine. 2nd ed. Boston: Little, Brown & Company; 1992.

4. Landrigan PJ. The uses of epidemiology in the study of neurotoxic pollutants - lessons from the workplace. Int J Mental Health 1985; 14:44-63.

5. Landrigan PJ. Arsenic. In: Rom WN, editor. Environmental and Occupational Medicine. Boston: Little, Brown and Co; 1983.

6. Landrigan PJ. Occupational and community exposures to toxic metals - lead, cadmium, mercury and arsenic. Western J Med 1982; 137:532-539.

7. Landrigan PJ. Arsenic: State of the art. Am J Ind Med 1981; 2:5-14.

8. Landrigan PJ, Baker EL. Exposure of children to heavy metals from smelters: Epidemiology and toxic consequences. Environ Res 1981; 25:204-244.

9. Landrigan PJ, Costello RJ, Stringer WT. Occupational exposure to arsine. An epidemiologic reappraisal of current standards. Scand J Work Environ Health 1982; 8:169-177.

10. Morse DL, Harrington JM, Housworth J, Landrigan PJ, Kelter A. Arsenic exposure in multiple environmental media in children near a smelter. Clin Toxicol 1979; 14:389-399.

11. Rosenberg MJ, Landrigan PJ, Crowley S. Low-level arsenic exposure in wood processing plants. Am J Ind Med 1980; 1:99-108.

Artificial Turf

1. Landrigan PJ. Artificial turf fields pose safety issues. The Journal News, December 11, 2008.

Asbestos

1. Harrington J, Craun G, Meigs J, Landrigan PJ, Flannery J, Woodhull R. An investigation of the use of asbestos cement pipes for public water supply and the incidence of gastrointestinal cancer in Connecticut. Am J Epidemiol 1978; 107:96-103.

2. LaDou J, Landrigan PJ, Bailar JC III, Foa V, Frank A. A call for an international ban on asbestos. (commentary). Can Med Assoc J 2001; 164:489-490.

3. Landrigan PJ. Dr. T.K. joshi and asbestos in India: A message from the Collegium Ramazzini. Am J Ind Med 2004;45:125-128.

4. Landrigan PJ. The 2nd ADAO asbestos conference proceedings. (preface.) Am J Ind Med 2007; 50:51.

5. Landrigan PJ. Asbestos--still a carcinogen. New Engl J Med 1998; 338:1618-1619.

6. Landrigan PJ. Nonoccupational exposure to chrysotile asbestos and the risk of lung cancer (letter to the editor). New Engl J Med 1998;339:999-1002.

7. Landrigan PJ. Asbestos-related cancer. (letter). CA 1996; 46:254-255.

8. Landrigan PJ. Asbestos anxiety. New York Times Op-Ed:

9. Landrigan PJ. The third wave of asbestos disease: Exposure to asbestos in place. Public health control. Introduction. Ann NY Acad Sci 1991; 643:15-16.

10. Landrigan PJ. A population of children at risk of exposure to asbestos in place. In: The Third Wave of Asbestos Disease: Exposure to asbestos in place. Ann NY Acad Sci 1991; 643:283-286.

11. Landrigan PJ, DiLiberti JH, Graef JW, Jackson RJ, Nathenson G. American Academy of Pediatrics Committee on Environmental Hazards: Asbestos exposure in schools. Pediatrics 1987; 79:301-305.

12. Landrigan PJ, Etzel R. Chemical pollutants. In: Behrman R, editor. Nelson Textbook of Pediatrics. 16th ed. Philadelphia: WB Saunders Co; 1998.

13. Landrigan PJ, Golden AL, Markowitz SB. Occupational cancer in New York City firefighters. New York: United Firefighters Association and United Fire Officers Association; 1994.

14. Landrigan PJ, Nicholson WJ, Suzuki Y, Ladou J. The hazards of chrysotile asbestos: A critical review. Ind Health 1999; 37:271-280.

15. Landrigan PJ, Kazemi H. Asbestos and cancer. (letter) The Economist 1990; 316:7670.

16. Landrigan PJ, Soffritti M. Collegium Ramazzini statement on the Tokyo declaration banning asbestos. Am J Ind Med 2005; 48:89.

17. Landrigan PJ, Soffritti M. Collegium Ramazzini call for an international ban on asbestos. Am J Ind Med 2005; 47:471.

18. Markowitz SB, Garibaldi K, Lilis R, Landrigan PJ. Asbestos exposure and fire fighting. In: The third wave of asbestos disease: exposure to asbestos in place. Ann NY Acad Sci 1991; 643:573-577.

19. McDiarmid MA, Collins MD, Landrigan PJ. Environmental toxins in child health. In: Proceedings of "child health in the inner-city IV" issues and answers for the 90s. Washington DC: Department of Pediatrics and Child Health, Howard University College of Medicine; 1994.

20. Nicholson WJ, Johnson EM, Harington JS, Melius JM, Landrigan PJ. Mesothelioma in the Quebec chrysotile mining and milling area. (letter). Science 1990; 248:796-799.

21. Nicholson WJ, Landrigan PJ. Asbestos: A status report. Current Issues in Public Health 1996; 2:118-123.

22. Nicholson WJ, Landrigan PJ. The carcinogenicity of chrysotile asbestos. In: Mehlman M, Upton A, editors. Advances in modern environmental toxicology. Princeton, NJ: Princeton Scientific Publishing Co; 1994.

23. Rosenstock L, Landrigan PJ. Occupational health: The intersection between clinical medicine and public health. Ann Rev Pub Health 1986; 7:337-356.

24. Stayner LT, Camargo MC, Reina M, Al-Alem U, Straif K and Landrigan PJ. A meta-analysis of the association between asbestos exposure and the risk of ovarian cancer. Presented at the EPICOH meeting.

Asthma

1. Claudio L, Torres T, Sanjurjo E, Sherman L, Landrigan PJ. Environmental health sciences education-A tool for achieving environmental equity and protecting our children. Environ Health Perspect 1998; 106:849-855.

2. Claudio L, Tulton L, Doucette J, Landrigan PJ. Socioeconomic factors and asthma hospitalization rates in New York City. J Asthma 1999; 36:343-350.

3. Ehrlich RI, Kattan M, Saltzberg DS, Grimm KT, Landrigan PJ, Lilienfeld DE. Passive smoking and urinary cotinine levels in acute and non-acute asthmatics. Proceedings of the American Pediatric Society/Society for Pediatric Research; 1990.

4. Ehrlich R, Kattan M, Godbold J, Saltzberg D, Grimm K, Landrigan PJ, Lilienfeld D. Childhood asthma and passive smoking: Urinary cotinine as a biomarker of exposure. Am Rev Respir Dis 1992; 145:594-599.

5. Etzel RA, Balk SJ, Reigart JR, Landrigan PJ. Environmental health for practicing pediatricians. Indian Pediatrics 2003:853.

6. Goldman L, Falk H, Landrigan PJ, Balk SJ, Reigart JR, Etzel RA. Environmental pediatrics and its impact on government health policy. Pediatrics 2004;113:1146-1157.

7. Landrigan PJ. Doctor's orders: Healthy kids need a healthy planet. Creation Care (Spring 1999): 6-7,17-18.

8. Asthma in American Children. Congressional Staff Briefing: Asthma and the Environment: Protecting our Children [Landrigan PJ]. 1-4 (1999).

9. Landrigan PJ, Crain E, Etzel R, Gitterman B, Oberg C, Scheidt P. The need for a new subspecialty in environmental pediatrics. Global Forum for Children's Environmental Health; 7-11 September 2001.

10. Landrigan PJ, Schechter CB, Lipton JM, Fahs MC, Schwartz J. Environmental pollutants and disease in American children: Estimates of morbidity, mortality, and costs for lead poisoning, asthma, cancer, and developmental disabilities. Environ Health Perspect 2002; 110:721-728.

11. Landrigan PJ, Forman J, Galvez M, Newman B, Engel SM, Chemtob C. Impact of September 11 World Trade Center disaster on children and pregnant women. Mount Sinai J Med 2008; 75:129.

12. Liss GM, Halperin WE, Landrigan PJ. Occupational asthma in a home pieceworker. Arch Environ Health 1986; 41:326-359.

13. Moline J, Landrigan PJ. Insights on asthma at work. (book review.) The Lancet 1999; 354:1217.

14. Rauh VA, Landrigan PJ, Claudio L. Housing and health: Intersection of poverty and environmental exposures. Ann NY Acad Sci 2008;1136: 276-288.

15. Roy A, Sheffield PE, Wong K, Trasande L. Economic consequences of subchronic air pollutant exposure for pediatric asthma hospitalizations. Pediatric Academic Societies Meeting; May 2010.

16. Trasande L, Landrigan PJ, Haynes KA, Falk R. Environmental pollutants and disease in New York State's children: Estimates of morbidity, mortality and costs for lead poisoning, asthma, cancer and developmental disabilities. Eastern Society of Pediatric Research; March 5, 2005.

17. Trasande L, Thurston GD. The role of air pollution in asthma and other pediatric morbidities. J Allergy Clin Immunol 2005; 115(4):689-699.

18. Zajac L, Sprecher E, Landrigan PJ, Trasande L. A systematic review of US state environmental legislation and regulation with regards to the prevention of neurodevelopmental disabilities and asthma. Environmental Health 2009; 2:9.

Attention Deficit Hyperactivity Disorder and Attention Deficit Disorder

1. Braganaza SF, Galvez MP, Ozuah PO. When parents ask about diet therapy for ADHD. Contemporary Pediatrics 2006 May 1; 23(5):47-9.

2. Landrigan PJ, Slutsky J. Are learning disabilities linked to environmental toxins? Learning Disabilities Journal 2004; 15:7.

Autism

1. Landrigan PJ. What causes autism? Exploring the environmental contribution. Curr Opin Pediatr 2010; 2:219-225.

2. Landrigan PJ, Slutsky J. Are learning disabilities linked to environmental toxins? Learning Disabilities Journal 2004; 15:7.

Benzene

1. Landrigan PJ. Benzene. In: William N. Rom, editor. Environmental and Occupational Medicine. Lippincott-Raven Publishers; 2007.

2. Landrigan PJ. Benzene and blood: One hundred years of evidence. (editorial). Am J Ind Med 1996; 29:225-226.

3. Landrigan PJ. Risk assessment and cost/benefit analysis for new regulations. New Solutions 1995; 5:85-91.

4. Landrigan PJ. Benzene. In: Rom WN, editor. Environmental and Occupational Medicine. 2nd ed. Boston: Little, Brown & Company; 1992.

5. Landrigan PJ. Occupational leukemia. State of the Art Reviews 1987; 2:179-188.

6. Landrigan PJ. Principles for application of porphyrin markers in epidemiological studies. Ann NY Acad Sci 1987; 514:323-326.

7. Landrigan PJ. Benzene and leukemia. Am J Ind Med 1987; 11:605-606.

8. Landrigan PJ. The uses of epidemiology in the study of neurotoxic pollutants - Lessons from the workplace. Int J Mental Health 1985; 14:44-63.

9. Landrigan PJ, Golden AL, Markowitz SB. Occupational cancer in New York City firefighters. New York: United Firefighters Association and United Fire Officers Association; 1994.

10. Landrigan PJ. Critical assessment of epidemiologic studies on the human carcinogenicity of 1,3-butadiene. Environ Health Perspect 1990; 86:143-147.

11. Landrigan PJ, Rinsky RA. The application of epidemiology to the prevention of occupational cancer. J Toxicol 1984; 22:209-238.

12. Nicholson WJ, Landrigan PJ. Quantitative assessment of lives lost due to delay in the regulation of occupational exposure to benzene. Environ Health Perspect 1989; 82:185-188.

13. Rinsky RA, Hornung RW, Landrigan PJ. Benzene and leukemia: A review of the literature and a risk assessment. (letter). Am J Epidemiol 1989; 129:1084-1086.

14. Rinsky RA, Smith AB, Hornung R, Filloon TG, Young RJ, Okun AH, Landrigan PJ. Benzene and leukemia. An epidemiologic risk assessment. New Engl J Med 1987; 316:1044-1050.

15. Rinsky RA, Smith AB, Hornung R, Okun AH, Landrigan PJ. Benzene and leukemia. (letter). New Engl J Med 1987; 317:1027-1029.

16. Rosenstock L, Landrigan PJ. Occupational health: The intersection between clinical medicine and public health. Ann Rev Pub Health 1986; 7:337-356.

Bisphenol A

1. Engel SM, Levy B, Liu Z, Kaplan D, Wolff MS. Xenobiotic phenols in early pregnancy amniotic fluid. Reprod Toxicol 2006; 21:110-112.

2. Teitelbaum SL, Calafat A, Britton J, Silva M, Wolff MS, Reidy J, Brenner b, Galvez M, Ye x. How representative is a single urine sample of a six-moth average for urinary phthalate metabolites and bisphenol A? Epidemiol 2006 November; 17(6): S335-S336.

3. Wolff MS, Britton JA, Boguski L, Hochman S, Maloney N, Serra N, Liu Z, Berkowitz G, Larson S, Forman J. Environmental exposures and puberty in inner-city girls. Environ Res 2008; 107:393-400.

Cadmium

1. Baker EL Jr, Hayes CG, Landrigan PJ, Handke JL, Leger RT, Housworth WJ, Harrington JM. A nationwide survey of heavy metal absorption in children living near primary copper, lead, and zinc smelters. Am J Epidemiol 1977; 106:261-273.

2. Baker EL Jr, Peterson WA, Holtz JL, Coleman C, Landrigan PJ. Subacute cadmium intoxication in jewelry workers: An evaluation of diagnostic procedures. Arch Environ Health 1979; 34:173-177.

3. Greenberg A, Parkinson DK, Fetterolf DE, Puschett JB, Ellis KJ, Wielopolski L, Vaswani AN, Cohn SH, Landrigan PJ. Effects of elevated lead and cadmium burdens on renal function and calcium metabolism. Arch Environ Health 1986; 4:69-76.

4. Landrigan PJ. Occupational and community exposures to toxic metals - lead, cadmium, mercury and arsenic. Western J Med 1982; 137: 532-539.

5. Landrigan PJ. Epidemiology of lead and other metal poisonings in children. In: Chemical and Radiation Hazards to Children. Report of the 84th Ross Conference on Pediatric Research. Columbus, Ohio: Ross Laboratories; 1982.

6. Landrigan PJ, Baker EL. Exposure of children to heavy metals from smelters: Epidemiology and toxic consequences. Environ Res 1981; 25:204-244.

7. Landrigan PJ, Goyer RA, Clarkson TW, Sandler DP, Smith JH, Thun MJ, Weeden RP. The work-relatedness of renal disease. Arch Environ Health 1984; 39:225-230.

8. Lilis R, Landrigan PJ. Renal and urinary tract disorders. In: Wegman DH, Levy B, editors. Occupational Health 3rd ed. Boston: Little, Brown & Co; 1994.

9. Wysowski DK, Landrigan PJ, Ferguson SW, Fontaine RE, Tsongas TA, Porter B. Cadmium exposure in a community near a smelter. Am J Epidemiol 1978; 107:27-35.

Cancer

1. Ahn J, Gammon MD, Santella RM, Gaudet MM, Britton JA, Teitelbaum SL, Terry MB, Neugut AI, Ambrosone CB. No association between glutathione peroxidase Pro198Leu polymorphism and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2005; 14(10):2459-2461.

2. Ahn J, Gammon MD, Santella RM, Gaudet MM, Britton JA, Teitelbaum SL, Terry MB, Neugut AI, Eng SM, Zhang Y, Garza C, Ambrosone CB. Effects of glutathione S-transferase A1 (GSTA1) genotype and potential modifiers on breast cancer risk. Carcinogesis 2006; 27(9):1876-1882.

3. Ahn J, Gammon MD, Santella RM, Gaudet MM, Britton JA, Teitelbaum SL, Terry MB, Nowell S, Davis W, Garza C, Neugut AI, Ambrosone CB. Associations between breast cancer risk and the catalase genotype, fruit and vegetable consumption, and supplement use. Am J Epidemiol 2005; 162(10):943-952.

4. Baker D, Levin SM, Landrigan PJ, Frumin E, Brathwaite M, Towne W. Testicular cancer, industrial bronchitis, and dermatitis among leather tanning workers. Proceedings of Annual Meeting of American Public Health Association; November 13-17 1988.

5. Bradshaw PT, Sagiv SK, Kabat GC, Satia JA, Britton JA, Teitelbaum SL, Neugut AI, Gammon MD. Consumption of sweet foods and breast cancer risk: A case-control study of women on Long Island, New York. Cancer Causes Control 2009; 20(8):1509-15.

6. Bridbord K, Wagoner J, Blejer H, Landrigan PJ, Lemen R. The role of epidemiology in assessing the health effects of metals; September 14 1975.

7. Carroquino MJ, Galson SK, Licht J, Amler RW, Perera FP, Claxton LD, Landrigan PJ. The U.S. EPA conference on preventable causes of cancer in children: A research agenda. Environ Health Perspect 1998; 106:867-873.

8. Chen J, Gammon MD, Chan W, Palomeque C, Wetmur JG, Kabat GC, Teitelbaum SL, Britton JA, Terry MB, Neugut AI, Santella RM. One-carbon metabolism, MTHFR polymorphisms, and risk of breast cancer. Cancer Res 2005; 65(4):1606-1614.

9. Chen Y, Gammon MD, Teitelbaum SL, Britton JA, Terry MB, Shantakumar S, Eng SM, Wang Q, Gurvich I, Neugut AI, Santella RM, Ahsan H. Estrogen-biosynthesis gene CYP17 and its interactions with reproductive, hormonal and lifestyle factors in breast cancer risk: Results from the Long Island Breast Cancer Study Project. Carcinogenesis 2008; 29(4):766-71.

10. Cleveland RJ, Eng SM, Abrahamson PE, Britton JA, Teitelbaum SL, Neugut AI, Gammon MD. Weight gain prior to diagnosis and survival from breast cancer. Cancer Epidemiology Biomarkers Preview 2007;16(9):1803-11.

11. Cleveland RJ, Gammon MD, Edmiston SN, Teitelbaum SL, Britton JA, Terry MB, Eng SM, Neugut AI, Santella RM, Conway K. IGF1 CA repeat polymorphisms, lifestyle factors and breast cancer risk in the Long Island Breast Cancer Study Project. Carcinogenesis 2006; 27(4):758-765.

12. Cleveland RJ, Gammon MD, Long CM, Gaudet MM, Eng SM, Teitelbaum SL, Neugut AI, Santella RM. Common genetic variations in the LEP and LEPR genes, obesity and breast cancer incidence and survival. Breast Cancer Res Treat 2010; 120(3):745-752.

13. Cohn BA, Cirrilo PM, Sholta RI, Wolff MS. DDT does take its toll on some people (letter). Wall Street Journal.

14. Cohn BA, Wolff MS, Cirillo PM, Sholtz RI. DDT and breast cancer in young women: New data on the significance of age at exposure Environ Health Perspect 2007; 115:1406-1414.

15. Crew KD, Gammon MD, Steck SE, Hershman DL, Cremers S, Dworakowski E, Shane E, Terry MB, Desai M, Teitelbaum SL, Neugut AI, Santella RM. Association between plasma 25-hydroxyvitamin D and breast cancer risk. Cancer Prev Res (Phil Pa) 2009; 2(6):598-604.

16. Crew KD, Gammon MD, Terry MB, Zhang FF, Agrawal M, Eng SM, Sagiv SK, Teitelbaum SL, Neugut AI, Santella RM. Genetic polymorphisms in the apoptosis-associated genes FAS and FASL and breast cancer risk. Carcinogenesis 2007; 28(12):2548-51.

17. Crew KD, Gammon MD, Terry MB, Zhang FF, Zablotska LB, Agrawal M, Shen J, Long CM, Eng SM, Sagiv SK, Teitelbaum SL, Neugut AI, Santella RM. Polymorphisms in nucleotide excision repair genes, polycyclic aromatic hydrocarbon-DNA adducts, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2007; 16(10):2033-41.

18. Eng SM, Gammon MD, Terry MB, Kushi LH, Teitelbaum SL, Britton JA, Neugut AI. Body size changes in relation to postmenopausal breast cancer among women on Long Island, New York. Am J Epidemiol 2005; 162(3):229-237.

19. Epstein SS, Swartz JB, Bailar J, Bingham E, Dahlsten DL, Infante PR, Landrigan PJ, Nicholson WJ, Lappé M, Moreno M, Legator M, Mirer F, Moure R, Silverstein M, Ozonoff D, Paigen B, Warren J. April 17, 1987 ames article. (letter). Science 1988; 240:1043-1045.

20. Etzel RA, Balk SJ, Reigart JR, Landrigan PJ. Environmental health for practicing pediatricians. Indian Pediatrics 2003:853.

21. Fink BN, Gaudet MM, Britton JA, Abrahamson PE, Teitelbaum SL, Jacobson J, Bell P, Thomas JA, Kabat GC, Neugut AI, Gammon MD. Fruits, vegetables, and micronutrient intake in relation to breast cancer survival. Breast Cancer Res Treat 2006; 98(2):199-208.

22. Fink BN, Steck SE, Wolff MS, Britton JA, Kabat GC, Gaudet MM, Abrahamson PE, Bell P, Schroeder JC, Teitelbaum SL, Neugut AI, Gammon MD. Dietary flavonoid intake and breast cancer survival on Long Island. Cancer Epidemiol Biomarkers Prev 2007; 16:2285-2292.

23. Fink BN, Steck SE, Wolff MS, Britton JA, Kabat GC, Gaudet MM, Abrahamson PE, Bell P, Schroeder JC, Teitelbaum SL, Neugut AI, Gammon MD. Dietary flavonoid intake and breast cancer survival among women on Long Island. Cancer Epidemiol Biomarkers Prev 2007; 16(11):2285-92.

24. Fink BN, Steck SE, Wolff MS, Britton JA, Kabat GC, Schroeder JC, Teitelbaum SL, Neugut AI, Gammon MD. Dietary flavonoid intake and breast cancer risk among women on Long Island. Am J Epidemiol 2006; 165(5):514-23.

25. Fink BN, Steck SE, Wolff MS, Kabat GC, Gammon MD. Construction of a flavonoid database for assessing intake in a population-based sample of women on Long Island, New York. Nutr Cancer 2006; 56:57-66.

26. Frumin E, Brathwaite M, Towne W, Levin SM, Baker DB, Monaghan SV, Landrigan PJ, Marshall EG, Melius JM. Testicular cancer in leather workers - Fulton County. Mmwr 1988; 38:105-114.

27. Galson SK, Carroquino MJ, Landrigan PJ. Introduction to conference on preventable causes of cancer in children. Environ Health Perspect 1998; 106:865-866.

28. Gammon MD, Fink BN, Steck SE, Wolff MS. Soy intake and breast cancer: Elucidation of unanswered question. Br J Ca 2008; 98:2-3.

29. Gaudet MM, Bensen JT, Schroeder J, Olshan AF, Terry MB, Eng SM, Teitelbaum SL, Britton JA, Lehman TA, Neugut AI, Ambrosone CB, Santella RM, Gammon MD. Catechol-O-methyltransferase haplotypes and breast cancer among women on Long Island, New York. Breast Cancer Res Treat 2006; 99(2):235-240.

30. Gaudet MM, Gammon MD, Bensen JT, Sagiv SK, Shantakumar S, Teitelbaum SL, Eng SM, Neugut AI, Santella RM. Genetic variation of TP53, polycyclic aromatic hydrocarbon-related exposures, and breast cancer risk among women on Long Island, New York. Breast Cancer Res Treat 2008; 108(1):93-99.

31. Gaudet MM, Gammon MD, Santella RM, Britton JA, Teitelbaum SL, Eng SM, Terry MB, Bensen JT, Schroeder J, Olshan AF, Neugut AI, Ambrosone CB. MnSOD val-9Ala genotype, pro- and anti-oxidant environmental modifiers, and breast cancer among women on Long Island, New York. CCC 2005; 16(10):1225-1234.

32. Golden AL, Markowitz SB, Landrigan PJ. The risk of cancer in firefighters. Occup Med 1995; 10:803-820.

33. Golembesky AK, Gammon MD, North KE, Bensen JT, Schroeder JC, Teitelbaum SL, Neugut AI, Santella RM. Peroxisome proliferator-activated receptor-alpha (PPARA) genetic polymorphisms and breast cancer risk: A Long Island ancillary study. Carcinogenesis 2008; 29(10):1944-9.

34. Gordon RR, Hunter KW, La Merrill M, Sørensen P, Threadgill DW, Pomp D. Genotype X diet interactions in mice predisposed to mammary cancer: II. tumors and metastasis. Mamm Genome 2008; 13(3):179-89.

35. Gordon, R. La Merrill, M, Hunter, K, Threadgill, D, and Pomp D. Dietary fat-dependent transcriptional architecture and copy number alterations associated with modifiers of mammary cancer metastasis. Clin Exp Metastasis 2010; 27(5):279-293.

36. Greenlee H, Gammon MD, Abrahamson PE, Gaudet MM, Terry MB, Hershman DL, Desai M, Teitelbaum SL, Neugut AI, Jacobson JS. Prevalence and predictors of antioxidant supplement use during breast cancer treatment: The Long Island Breast Cancer Study Project. Cancer 2009; 115(14):3271-3282.

37. Halperin WE, Goodman M, Stayner L, Elliott LJ, Keenlyside RA, Landrigan PJ. Nasal cancer in a worker exposed to formaldehyde. JAMA 1983; 249:510-512.

38. Jackson RJ, DiLiberti JH, Landrigan PJ, Nathenson G, Needleman HL, Brown AK, Etzel RA, Falk H, Miller RW, Rogan W. American Academy of Pediatrics, committee on environmental hazards: Radon exposure: A hazard to children. Pediatrics 1989; 83:799-802.

39. Kabat GC, O'Leary ES, Gammon MD, Sepkovic DW, Teitelbaum SL, Britton JA, Terry MB, Neugut AI, Bradlow HL. Estrogen metabolism and breast cancer. Epidemiol 2006; 17(1):80-88.

40. Kraut A, Chan E, Abe T, Hall NE, Landrigan PJ. Completeness of case ascertainment of the State Cancer Registry. J Med Soc NJ 1992; 89:772-773.

41. Kraut A, Chan E, Lioy P, Cohen F, Goldstein B, Landrigan PJ. Epidemiologic investigation of a cancer cluster in professional football players. Environ Res 1991; 56:131-143.

42. La Merrill M, Baston DS, Denison MS, Birnbaum LS, Pomp D, Threadgill DW. Mouse breast cancer model-dependent changes in metabolic syndrome-associated phenotypes caused by maternal dioxin exposure and dietary fat. Am J Physiol Endocrinol Metab 2009; 296(1):203-210.

43. La Merrill M, Baston DS, Denison MS, Birnbaum LS, Pomp D, Threadgill DW. Mouse breast cancer model-dependent changes in metabolic syndrome-associated phenotypes caused by maternal dioxin exposure and dietary fat. Am J Physiol Endocrinol Metab 2008; 269(1):E203-10.

44. La Merrill M, Gordon RR, Hunter KW, Threadgill DW, Pomp D. Dietary fat alters pulmonary metastasis of mammary cancers through cancer autonomous and non-autonomous changes in gene expression. Clin Exp Metastasis 2010; 27(2):107-116.

45. La Merrill M, Harper R, Birnbaum LS, Cardiff RD, Threadgill DW. Maternal dioxin exposure combined with a diet high in fat increases mammary cancer incidence in mice. Environ Health Perspect 2010; 118(5):596-601.

46. La Merrill M, Kuruvilla BS, Pomp D, Birnbaum LS, Threadgill DW. Dietary fat alters body composition, mammary development, and cytochrome p450 induction after maternal TCDD exposure in DBA/2J mice with low-responsive aryl hydrocarbon receptors. Environ Health Perspect 2009; 117(9):1414-1419.

47. Landrigan PJ. Why not use it all? Another view. Environ Health Perspect 1999; 107:a546.

48. Landrigan PJ. Doctor's orders: Healthy kids need a healthy planet. Creation Care (Spring 1999): 6-7,17-18.

49. Landrigan PJ. Asbestos--still a carcinogen. New Engl J Med 1998; 338:1618-1619.

50. Landrigan PJ. Nonoccupational exposure to chrysotile asbestos and the risk of lung cancer (letter to the editor). New Engl J Med 1998; 339:999-1002.

51. Landrigan PJ. Angiosarcoma of the liver among polyvinyl chloride workers - Kentucky. MMWR 1997; 46:99-101.

52. Landrigan PJ. The prevention of occupational cancer. CA 1996; 46:67-69.

53. Landrigan PJ. Asbestos-related cancer. (letter). CA 1996; 46:254-255.

54. Landrigan PJ. Childhood leukemias. New Engl J Med 1995; 333:1286.

55. Landrigan PJ. Risk assessment and cost/benefit analysis for new regulations. New Solutions 1995; 5:85-91.

56. Landrigan PJ. Health risks of creosotes. Questions & answers. JAMA 1993; 269:1309.

57. Landrigan PJ. A population of children at risk of exposure to asbestos in place. In: The third wave of asbestos disease: Exposure to asbestos in place. Ann NY Acad Sci 1991; 643:283-286.

58. Landrigan PJ. Critical review of epidemiology studies on the human carcinogenicity of formaldehyde. Proceedings of the annual meeting of the Collegium Ramazzini; December 1, 1988.

59. Landrigan PJ. Silicosis. Occup Med 1987; 2:319-326.

60. Landrigan PJ. Occupational leukemia. State of the Art Reviews 1987; 2:179-188.

61. Landrigan PJ. Benzene and leukemia. Am J Ind Med 1987; 11:605-606.

62. Landrigan PJ. Toxic exposures and psychiatric disease - Lessons from the epidemiology of cancer. Acta Psychiatr Scand 1983; 67(303):6-15.

63. Landrigan PJ. Cancer: The right to know. The Cincinnati Enquirer. April 2. Editorial.

64. Landrigan PJ. Toxic exposures and psychiatric diseases: An epidemiologic approach. In: Proceedings of the Third World Congress of Biological Psychiatry. Amsterdam: Elveiser; 1981.

65. Landrigan PJ, Baker DB, Markowitz SB, Nicholson WJ. Cancer prevention in the workplace. In: Greenwald P, Kramer BS, Weed DL, editor. The Science and Practice of Cancer Prevention and Control. 3rd ed. New York: Marcel-Dekker; 1994.

66. Landrigan PJ, Crain E, Etzel R, Gitterman B, Oberg C, Scheidt P. The need for a new subspecialty in environmental pediatrics. Global Forum for Children's Environmental Health; 7-11 September 2001.

67. Landrigan PJ, DiLiberti JH, Graef JW, Jackson RJ, Nathenson G. American Academy of Pediatrics committee on environmental hazards: Asbestos exposure in schools. Pediatrics 1987; 79:301-305.

68. Landrigan PJ, Etzel R. Chemical pollutants. In: Behrman R, editor. Nelson Textbook of Pediatrics. 16th ed. Philadelphia: WB Saunders Co; 1998.

69. Landrigan PJ, Gehlbach SH, Graef JW, Hanson JW, Nathenson G. Smokeless tobacco - A carcinogenic hazard to children. Committee on environmental hazards. Pediatrics 1985; 76:1009-1011.

70. Landrigan PJ, Golden AL, Markowitz SB. Occupational cancer in New York City firefighters. New York: United Firefighters Association and United Fire Officers Association; 1994.

71. Landrigan PJ, Markowitz S, Baker DB. Cancer prevention in the workplace. In: Greenwald P, Kramer BS, Weed DL, editor. Cancer Prevention and Control. 2nd ed. New York: Marcel Dekker; 2001.

72. Landrigan PJ, Mattison DR, Boardman B, Bruckner JV, Jackson RJ, Karol MH, Krewski D, Weil WB. Children's health, susceptibility and regulatory approaches to reducing risk from chemical carcinogens. (letter to the editor). Environ Health Perspect 2001; 109:A412.

73. Landrigan PJ, Nicholson WJ, Suzuki Y, Ladou J. The hazards of chrysotile asbestos: A critical review. Ind Health 1999; 37:271-280.

74. Landrigan PJ, Rinsky RA, Waxweiler RJ. Epidemiologic assessment of occupational illness caused by exposures to petrochemicals. Alaska: The Alaska Public Health Association; 1982.

75. Landrigan PJ, Schechter CB, Lipton JM, Fahs MC, Schwartz J. Environmental pollutants and disease in American children: Estimates of morbidity, mortality, and costs for lead poisoning, asthma, cancer, and developmental disabilities. Environ Health Perspect 2002; 110:721-728.

76. Landrigan PJ. Critical assessment of epidemiologic studies on the human carcinogenicity of 1,3-butadiene. Environ Health Perspect 1990; 86:143-147.

77. Landrigan PJ, Kazemi H. Asbestos and cancer. (letter) The Economist 1990; 316:7670.

78. Landrigan PJ, Rinsky RA. The application of epidemiology to the prevention of occupational cancer. J Toxicol 1984; 22:209-238.

79. Levin SM, Baker DB, Landrigan PJ, Monaghan SV, Frumin E, Braithwaite M, Towne W. Testicular cancer in leather tanners exposed to dimethyl formamide. Lancet 1987; 22:1154.

80. Lilis R, Landrigan PJ. Renal and urinary tract disorders. In: Wegman DH, Levy B, editors. Occupational Health 3rd ed. Boston: Little, Brown & Co; 1994.

81. McCarty KM, Santella RM, Steck SE, Cleveland RJ, Ahn J, Ambrosone CB, North K, Sagiv SK, Eng SM, Teitelbaum SL, Neugut AI, Gammon MD. PAH-DNA adducts, cigarette smoking, GST polymorphisms, and breast cancer risk. Environ Health Perspect 2009; 117(4):552-8.

82. Moline JM, Golden AL, Bar-Chama N, Smith E, Rauch ME, Chapin RE, Perreault SD, Schrader SM, Suk WA, Landrigan PJ. Exposure to hazardous substances and male reproductive health: A research framework. Environ Health Perspect 2000; 108:803-813.

83. Nelson N, Levine RJ, Albert RE, Blair AE, Griesemer RA, Landrigan PJ, Stayner LT, Swenberg JA. Contribution of formaldehyde to respiratory cancer. Environ Health Perspect 1986; 70:23-25.

84. Nicholson WJ, Johnson EM, Harington JS, Melius JM, Landrigan PJ. Mesothelioma in the Quebec chrysotile mining and milling area. (letter). Science 1990; 248:796-799.

85. Rinsky RA, Hornung RW, Landrigan PJ. Benzene and leukemia: A review of the literature and a risk assessment. (letter). Am J Epidemiol 1989; 129:1084-1086.

86. Rinsky RA, Melius JM, Hornung RW, Zumwalde RD, Waxweiler RJ, Landrigan PJ, Bierbaum PJ, Murray WE Jr. Case-control study of lung cancer in civilian employees at the Portsmouth naval shipyard, Kittery, Maine. Am J Epidemiol 1988;127:55-64.

87. Rinsky RA, Smith AB, Hornung R, Okun AH, Landrigan PJ. Benzene and leukemia. (letter). New Engl J Med 1987; 317:1027-1029.

88. Rinsky RA, Zumwalde RD, Waxweiler RJ, Murray WE Jr, Bierbaum PJ, Landrigan PJ. Cancer mortality at a naval nuclear shipyard. Lancet 1981; 1:231-243.

89. Rinsky RA, Landrigan PJ. Data on lung cancer in radiation workers. Proc Royal Soc Med 1983; 76:324-325.

90. Rosenstock L, Landrigan PJ. Occupational health: The intersection between clinical medicine and public health. Ann Rev Pub Health 1986; 7:337-356.

91. Rossner P Jr, Gammon MD, Terry MB, Agrawal M, Zhang FF, Teitelbaum SL, Eng SM, Gaudet MM, Neugut AI, Santella RM. Relationship between urinary 15-F2t-isoprostane and 8-oxodeoxyguanosine levels and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2006; 15(4):639-644.

92. Rossner P Jr, Gammon MD, Zhang YJ, Terry MB, Hibshoosh H, Memeo L, Mansukhani M, Long CM, Garbowski G, Agrawal M, Kalra TS, Gaudet MM, Teitelbaum SL, Neugut AI, Santella RM. Mutations in p53, p53 protein overexpression and breast cancer survival. J Cell Mol Med 2009; 13(9B):3847-3857.

93. Rossner P Jr, Gammon MD, Zhang YJ, Terry MB, Hibshoosh H, Memeo L, Mansukhani M, Long CM, Garbowski G, Agrawal M, Kalra TS, Gaudet MM, Teitelbaum SL, Neugut AI, Santella RM. Mutations in p53, p53 protein overexpression and breast cancer survival. J Cell Mol Med 2008; 13(9B):3847-57.

94. Rossner P Jr, Terry MB, Gammon MD, Agrawal M, Zhang FF, Ferris JS, Teitelbaum SL, Eng SM, Gaudet MM, Neugut AI, Santella RM. Plasma protein carbonyl levels and breast cancer risk. J Cell Mol Med 2007; 11(5):1138-1148.

95. Rossner P Jr, Terry MB, Gammon MD, Zhang FF, Teitelbaum SL, Eng SM, Sagiv SK, Gaudet MM, Neugut AI, Santella RM. OGG1 polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2006; 15(4):811-815.

96. Sagiv SK, Gaudet MM, Eng SM, Abrahamson PE, Shantakumar S, Teitelbaum SL, Bell P, Thomas JA, Neugut AI, Santella RM, Gammon MD. Polycyclic aromatic hydrocarbon-DNA adducts and survival among women with breast cancer. Environ Res 2009; 109(3):287-91.

97. Sagiv SK, Gaudet MM, Eng SM, Abrahamson PE, Shantakumar S, Teitelbaum SL, Britton JA, Bell P, Thomas JA, Neugut AI, Santella RM, Gammon MD. Active and passive cigarette smoke and breast cancer survival. Ann Epidemiol 2007; 17(5):385-93.

98. Selikoff IJ, Landrigan PJ. The third epidemiological revolution. J Occup Med and Toxicol 1992; 1:7-8.

99. Shantakumar S, Gammon MD, Eng SM, Sagiv SK, Gaudet MM, Teitelbaum SL, Britton JA, Terry MB, Paykin A, Young TL, Wang LW, Wang Q, Stellman SD, Beyea J, Hatch M, Camann D, Prokopczyk B, Kabat GC, Levin B, Neugut AI, Santella RM. Residential environmental exposures and other characteristics associated with detectable PAH-DNA adducts in peripheral mononuclear cells in a population-based sample of adult females. J Expo Anal Environ Epidemiol 2005; 15(6):482-490.

100. Shantakumar S, Terry MB, Paykin A, Teitelbaum SL, Britton JA, Moorman PG, Kritchevsky SB, Neugut AI, Gammon MD. Age and menopausal effects of hormonal birth control and hormone replacement therapy in relation to breast cancer risk. Am J Epidemiol 2007; 165(10):1187-98.

101. Shantakumar S, Terry MB, Teitelbaum SL, Britton JA, Millikan RC, Moorman PG, Neugut AI, Gammon MD. Reproductive factors and breast cancer risk among older women. Breast Cancer Res Treat 2006; 102(3):365-74.

102. Shen J, Beth Terry M, Gammon MD, Gaudet MM, Teitelbaum SL, Eng SM, Sagiv SK, Neugut AI, Santella RM. IGHMBP2 Thr671Ala polymorphism might be a modifier for the effects of cigarette smoking and PAH-DNA adducts to breast cancer risk. Breast Cancer Res Treat 2006; 99(1):1-7.

103. Shen J, Gammon MD, Terry MB, Teitelbaum SL, Eng SM, Neugut AI, Santella RM. Xeroderma pigmentosum complementation group C genotypes/diplotypes play no independent or interaction role with polycyclic aromatic hydrocarbons-DNA adducts for breast cancer risk. Eur J Cancer 2008; 44(5):710-7.

104. Shen J, Gammon MD, Terry MB, Teitelbaum SL, Neugut AI, Santella RM. Genetic polymorphisms in the cyclooxygenase-2 gene, use of nonsteroidal anti-inflammatory drugs, and breast cancer risk. Breast Cancer Res 2006; 8(6):R71.

105. Shen J, Gammon MD, Terry MB, Wang L, Wang Q, Zhang F, Teitelbaum SL, Eng SM, Sagiv SK, Gaudet MM, Neugut AI, Santella RM. Polymorphisms in XRCC1 modify the association between polycyclic aromatic hydrocarbon-DNA adducts, cigarette smoking, dietary antioxidants, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2005; 14(2):336-342.

106. Shen J, Gammon MD, Terry MB, Wang Q, Bradshaw P, Teitelbaum SL, Neugut AI, Santella RM. Telomere length, oxidative damage, antioxidants and breast cancer risk. Int J Cancer 2009; 124(7):1637-43.

107. Shen J, Gammon MD, Wu HC, Terry MB, Wang Q, Bradshaw PT, Teitelbaum SL, Neugut AI, Santella RM. Multiple genetic variants in telomere pathway genes and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2010; 19(1):219-28.

108. Shen J, Terry MB, Gammon MD, Gaudet MM, Teitelbaum SL, Eng SM, Sagiv SK, Neugut AI, Santella RM. MGMT genotype modulates the associations between cigarette smoking, dietary antioxidants and breast cancer risk. Carcinogenesis 2005;26(12):2131-2137.

109. Sprague JE, Kitaura H, Zou W, Ye Y, Achilefu S, Weilbaecher KN, Teitelbaum SL, Anderson CJ. Noninvasive imaging of osteoclasts in parathyroid hormone-induced osteolysis using a 64Cu-labeled RGD peptide. J Nucl Med 2007; 48(2):311-318.

110. Stayner LT, Camargo MC, Reina M, Al-Alem U, Straif K and Landrigan PJ. A meta-analysis of the association between asbestos exposure and the risk of ovarian cancer. Presented at the EPICOH meeting; 2009.

111. Steck SE, Gaudet MM, Britton JA, Teitelbaum SL, Terry MB, Neugut AI, Santella RM, Gammon MD. Interactions among GSTM1, GSTT1 and GSTP1 polymorphisms, cruciferous vegetable intake and breast cancer risk. Carcinogenesis 2007; 28(9):1954-1959.

112. Steck SE, Gaudet MM, Eng SM, Britton JA, Teitelbaum SL, Neugut AI, Santella RM, Gammon MD. Cooked meat and risk of breast cancer--lifetime versus recent dietary intake. Epidemiology 2007; 18(3):373-82.

113. Talbott KE, Gammon MD, Kibriya MG, Chen Y, Teitelbaum SL, Long CM, Gurvich I, Santella RM, Ahsan H. A CYP19 (aromatase) polymorphism is associated with increased premenopausal breast cancer risk. Breast Cancer Res Treat 2008;111(2):481-7.

114. Teitelbaum SL, Gammon MD, Britton JA, Neugut AI, Levin B, Stellman SD. Reported residential pesticide use and breast cancer risk on Long Island, New York. Am J Epidemiol 2006; 165(6):643-51.

115. Terry MB, Gammon MD, Zhang FF, Knight JA, Wang Q, Britton JA, Teitelbaum SL, Neugut AI, Santella RM. ADH3 genotype, alcohol intake and breast cancer risk. Carcinogenesis 2006; 27(4):840-847.

116. Terry MB, Perrin M, Salafia CM, Zhang FF, Neugut AI, Teitelbaum SL, Britton J, Gammon MD. Preeclampsia, pregnancy-related hypertension, and breast cancer risk. Am J Epidemiol 2007; 165(9):1007-14.

117. Terry MB, Zhang FF, Kabat G, Britton JA, Teitelbaum SL, Neugut AI, Gammon MD. Lifetime alcohol intake and breast cancer risk. Ann Epidemiol 2006; 16(3):230-240.

118. Torres-Sanchez L, Galvan-Portillo M, Wolff MS, Lopez-Carrillo L. Dietary consumption of phytochemicals and breast cancer risk in mexican women. Public Health Nutr 2008; 20:1-7.

119. Trasande L, Landrigan PJ, Schechter CB Falk R. Environmental pollutants and disease in New York State's children: Estimates of morbidity, mortality and costs for lead poisoning, asthma, cancer and developmental disabilities. Eastern Society of Pediatric Research; March 5, 2005.

120. Wolff MS, Anderson HA, Britton JA, Rothman N. Pharmacokinetic variability and modern Epidemiology-The example of dichlorodiphenyltrichloroethane, body mass index, and birth cohort. Cancer Epidemiol Biomarkers Prev 2007; 16:1925-1930.

121. Wolff MS, Britton JA, Teitelbaum ST, Eng S, Deych E, Ireland K, Liu Z, Neugut AI, Santella RM, Gammon MD. Improving organochlorine biomarker models for cancer research. Cancer Epidemiol Biomarkers Prev 2005;1 4:2224-2236.

122. Wolff MS, Landrigan PJ. Environmental estrogens (letter). Science 1994; 266:525-528.

123. Xu X, Gammon MD, Wetmur JG, Bradshaw PT, Teitelbaum SL, Neugut AI, Santella RM, Chen J. B-vitamin intake, one-carbon metabolism, and survival in a population-based study of women with breast cancer. Cancer Epidemiol Biomarkers Prev 2008; 17(8):2109-16.

124. Xu X, Gammon MD, Wetmur JG, Rao M, Gaudet MM, Teitelbaum SL, Britton JA, Neugut AI, Santella RM, Chen J. A functional 19-base pair deletion polymorphism of dihydrofolate reductase (DHFR) and risk of breast cancer in multivitamin users. Am J Clin Nutr 2007; 85(4):1098-102.

125. Xu X, Gammon MD, Zeisel SH, Bradshaw PT, Wetmur JG, Teitelbaum SL, Neugut AI, Santella RM, Chen J. High intakes of choline and betaine reduce breast cancer mortality in a population-based study. FASEB J 2009; 23(11):4022-8.

126. Xu X, Gammon MD, Zeisel SH, Bradshaw PT, Wetmur JG, Teitelbaum SL, Neugut AI, Santella RM, Chen J. High intakes of choline and betaine reduce breast cancer mortality in a population-based study. FASEB J.

127. Xu X, Gammon MD, Zeisel SH, Lee YL, Wetmur JG, Teitelbaum SL, Bradshaw PT, Neugut AI, Santella RM, Chen J. Choline metabolism and risk of breast cancer in a population-based study. FASEB J 2008; 22(6):2045-52.

128. Xu X, Gammon MD, Zhang H, Wetmur JG, Rao M, Teitelbaum SL, Britton JA, Neugut AI, Santella RM, Chen J. Polymorphisms of one-carbon-metabolizing genes and risk of breast cancer in a population-based study. Carcinogenesis 2007; 28(7):1504-9.

129. Xu X, Gammon MD, Zhang Y, Bestor TH, Zeisel SH, Wetmur JG, Wallenstein S, Bradshaw PT, Garbowski G, Teitelbaum SL, Neugut AI, Santella RM, Chen J. BRCA1 promoter methylation is associated with increased mortality among women with breast cancer. Breast Cancer Res Treat 2009; 115(2):397-404.

130. Xu X, Gammon MD, Zhang Y, Cho YH, Wetmur JG, Bradshaw PT, Garbowski G, Hibshoosh H, Teitelbaum SL, Neugut AI, Santella RM, Chen J. Gene promoter methylation is associated with increased mortality among women with breast cancer. Breast Cancer Res Treat 2010;121(3):685-92

Carbon Monoxide

1. Smith D, Herbert R, Schechter C, Phillips R, Diamond J, Dahms TE, Landrigan PJ. Occupational coronary heart disease among bridge and tunnel officers. Can J Cardiology 1997; 13 (Supplement B):76B.

2. Smith D, Herbert R, Schechter C, Phillips R, Diamond J, Dahms TE, Landrigan PJ. Occupational coronary heart disease among bridge and tunnel officers. (poster). Fourth International Conference on Preventive Cardiology; June 1997.

Child Labor

1. Belville R, Pollack SH, Landrigan PJ. Adolescent work-related injury award rates in New York State. Proceedings of Annual Meeting of the American Public Health Association; 1991.

2. Belville R, Pollack S, Godbold J, Landrigan PJ. Occupational injuries among working adolescents in New York State. JAMA 1993; 269:2754-2759.

3. Carpenter DO, Chew FT, Damstra T, Lam LH, Landrigan PJ, Makalinao I, Peralta GL, Suk WA. Environmental threats to the health of children: The Asian perspective. Environ Health Perspect 2000; 108:989-992.

4. Eskenazi B, Landrigan PJ. Environmental health perspects and children's environmental health. (editorial). Environ Health Perspect 2002; 110:A559-A560.

5. Landrigan PJ. Child labor: A re-emergent threat. Am J Dis Child 1993; 24:267-268.

6. Landrigan PJ. Child labor law violations. California Pediatrician 1990 (Fall):35-36.

7. Landrigan PJ, Belville R. The dangers of illegal child labor. Am J Dis Child 1993; 147:1029-1030.

8. Landrigan PJ, Costa Dias E, Sokas RK. Health hazards of child labor demographics. In: Herzstein JA, Bunn WB, Fleming LE, Harrington JM, Jeyaratnam J, Gardner IR, editor. International Occupational and Environmental Medicine; 1998.

9. Landrigan PJ, McCammon JB. Child labor still with us after all these years. Public Health Rep 1997; 112:466-473.

10. Landrigan PJ PS. Committee on environmental health. American Academy of Pediatrics. Statement on the hazards of child labor. Pediatrics 1995; 95:311-313.

11. Landrigan PJ, Pollack SH, Belville R. Child labor. In: Rom WN, editor. Environmental and Occupational Medicine. 2nd ed. Boston: Little, Brown and Company; 1992.

12. Landrigan PJ, Pollack SH, Belville R, Godbold JG. Child labor in the United States: Historical background and current crisis. Mt Sinai J Med 1992;59:498-503.

13. Landrigan PJ, Pollack SH, Belville R, Godbold JH. Child labor. Pediatric Annals 1995; 24:657-662.

14. Landrigan PJ, Pollack SH, Belville R, Godbold JH. Child labor: Epidemiology and health risks. In: Wallace H, editor. Maternal and Child Health. 4th ed. Oakland: Third Party Publishing Company; 1994.

15. Landrigan PJ, Pollack SH, Belville R, Godbold JH. Health hazards of child labor. In: Public Health and Preventive Medicine. 14th ed. Public Health and Preventive Medicine; 1993.

16. Landrigan PJ, Pollack SH, Godbold JG, Belville R. Child labor: Risks and prospects for prevention. In: Mehlman MA, Upton A, editors. The Identification and Control of Environmental and Occupational Diseases. Princeton NJ: Princeton Scientific Publications; 1994.

17. Landrigan PJ, Pollack SH, Godbold JG, Belville R. The health and safety hazards of child labor. In: Newman J, editor. Child Labor in the United States. New York: National Child Labor Committee; 1994.

18. Pollack S, Belville R, McConnell R, Landrigan PJ. Rates of work-related injury requiring hospitalization among teenagers in New York City. Proceedings of the 118th Annual Meeting of American Public Health Association; 1990.

19. Pollack S, Landrigan P, McConnell R, Belleville R. Epidemiologic studies on the health hazards of child labor. Proceedings of the 23rd International Congress on Occupational Health; 1990.

20. Pollack SH, Belville R, Landrigan PJ. Work-related head injuries in children. Proceedings of Annual Meeting of the American Public Health Association Meeting; 1991.

21. Pollack SH, Landrigan PJ, Mallino DL. Child labor in the 1990's: Prevalence and health hazards. Ann Rev Pub Health 1990; 11:359-375.

22. Pollack SH, Landrigan PJ. Health hazards of child labor. In: Wallace RB, editor. Public Health & Preventive Medicine. 15th Edition ed. McGraw Hill; 2007.

23. Pollack SH, Landrigan PJ, Rubinstein H. Child labor, environmental health. In: Maxcy-Rosenau-Last Textbook of Public Health. 13th ed; 1991.

24. Suk WA, Ruchirawat KM, Balakrishnan K, Berger M, Carpenter D, Damstra T, deGarbino Pronczuk J, Koh D, Landrigan PJ, Makalinao I, Sly PD, Xu Y, Zheng BS. Environmental threats to children's health in Southeast Asia and the Western Pacific. Environ Health Perspect 2003; 111:1340.

Chlorine

1. Wolff MS, Landrigan PJ. Organochlorine chemicals and children's health. (editorial). J Pediatr 2002;140:10.

Clinical Practice/Environment

1. Etzel RA, Crain EF, Gitterman BA, Oberg C, Scheidt P, Landrigan PJ. Pediatric environmental health competencies for specialists. Ambulatory Pediatrics 2003; 3:60-63.

2. Etzel RA, Balk SJ, Reigart JR, Landrigan PJ. Environmental health for practicing pediatricians. Indian Pediatrics 2003:853.

3. Goldman L, Falk H, Landrigan PJ, Balk SJ, Reigart JR, Etzel RA. Environmental pediatrics and its impact on government health policy. Pediatrics 2004; 113:1146-1157.

4. Landrigan PJ, Crain E, Etzel R, Gitterman B, Oberg C, Scheidt P. The need for a new subspecialty in environmental pediatrics. Global Forum for Children's Environmental Health; 7-11 September 2001.

5. Paulson JA, Karr CJ, Seltzer JM, Cherry DC, Sheffield PE, Cifuentes E, Buka I, Amler RW. Development of the pediatric environmental health specialty unit network in North America. Am J Public Health Am J Public Health; 99(3):S511-6.

6. Trasande L, Boscarino J, Graber N, Falk R, Schechter C, Galvez MP, Dunkel G, Geslani J, Moline J, Kaplan-Liss E, Miller RK, Korfmacher K, Carpenter D, Forman J, Balk SJ, Laraque D, Frumkin H, Landrigan PJ. The environment in pediatric practice: A study of New York pediatricians' attitudes, beliefs, and practices towards children's environmental health. J Urban Health 2006 Jul; 83(4):760-772.

7. Trasande L, Falk R, Schapiro ML, Landrigan PJ. The environment in pediatric practice: Surveys of pediatricians in three states. Pediatric Academic Societies Meeting; May 2007.

8. Trasande L, Landrigan PJ, Haynes KA, Falk R. The environment in pediatric practice: A pilot study of New York pediatricians' attitudes, beliefs and practices for children s environmental health. Eastern Society of Pediatric Research; March 4, 2005.

9. Trasande L, Newman N, Howe G, Kerwin BJ, Martin RJ, Long L, Gahagan SA, Weil WB. Pediatrician self-confidence and practices in managing and preventing diseases of environmental origin. Mount Sinai J Med 2010; 77(1):114-123.

10. Trasande L, Schapiro ML, Falk R, Haynes KA, Behrmann A, Vohmann M, Stremski ES, Eisenberg C, Evenstad C, Anderson HA, Landrigan PJ. Pediatrician attitudes, clinical activities, and knowledge of environmental health in Wisconsin. Wisconsin Medical Journal 2006; 105(2):50-54.

11. Trasande L, Ziebold C, Schiff JS, Wallinga D, McGovern P, Oberg CN. The environment in pediatric practice in Minnesota: Attitudes, beliefs, and practices towards children's environmental health. Minn Med 2008; 91(9):36-39.

 

 

Dioxins

1. Bienenfeld LA, Golden AL, Garland EJ. Consumption of fish from polluted waters by WIC participants in East Harlem. J Urban Health 2003; 80(2):849-858.

2. Landrigan PJ, Golden AL, Markowitz SB. Occupational cancer in New York City firefighters. New York: United Firefighters Association and United Fire Officers Association; 1994.

3. Wolff MS, Britton JA, Russo JC. TCDD and puberty in girls (letter). Environ Health Perspect 2005; 113:A17.

Drinking Water Contaminants

1. Baker EL, Landrigan PJ, Bertozzi PE, Field PH, Basteyns BJ, Skinner HG. Phenol poisoning due to contaminated drinking water. Arch Environ Health 1978; 33:89-94.

2. Rogan WJ, Brady MT. Committee on Environmental Health, Committee on Infectious Diseases. Drinking water from private wells and risks to children. Pedatri 2009; 123(6):1599-605.

3. Galvez MP, Peters R, Graber N, Forman J. Effective risk communication in children's environmental health: Lessons learned from 9/11. Pediatr Clin North Am 2007; 54(1):33-46.

4. Magdo HS, Forman J, Graber N, Newman B, Klein K, Satlin L, Amler RW, Winston JA, Landrigan PJ. Grand rounds: Nephrotoxicity in a young child exposed to uranium from contaminated well water. Environ Health Perspect 2007; 115(8):1237-1241.

5. Morse DL, Watson WN, Housworth J, Witherell LE, Landrigan PJ. Exposure of children to lead in drinking water. Am J Public Health 1979; 69:711-712.

6. Rogan WJ, Brady MT. Committee on Environmental Health, Committee on Infectious Diseases. Drinking water from private wells and risks to children. Pedatri 2009; 123(6):1123-37.

Endocrine Disruptors

1. Biro FM, Wolff MS, Kushi LH. Impact of yesterday's genes and today's diet and chemicals on tomorrow's women. J Pediatr Adolesc Gynecol 2009; 22:3-6.

2. Engel SM, Zhu C, Berkowitz GS, Calafat AM, Silva MJ, Miodovnik A, Wolff MS. Prenatal phthalate exposure and performance on the neonatal behavioral assessment scale in a multiethnic birth cohort. Neurotoxicology 2009 June 2009; 30(4):522-528.

3. Landrigan PJ, Garg A, Droller DBJ. Assessing the effects of endocrine disruptors in the National Children's Study. Environ Health Perspect 2003; 111:1678.

4. Landrigan PJ, Slutsky J. Are learning disabilities linked to environmental toxins? Learning Disabilities Journal 2004; 15:7.

5. Miodovnik A, Engel SM, Ye X, Zhu C, Soorya L, Silva MJ, Calafat AM, Wolf MS. Endocrine disruptors and childhood social impairment. In Submission.

6. Teitelbaum SL, Britton JA, Calafat AM, Ye X, Silva MJ, Reidy JA, Galvez MP, Brenner BL, Wolff MS. Temporal variability in urinary concentrations of phthalate metabolites, phytoestrogens and phenols among minority children in the United States. Environ Res 2008; 106:257-269.

7. Teitelbaum SL, Britton JA, Calafat AM, Ye X, Silva MJ, Reidy JA, Galvez MP, Brenner BL, Wolff MS. Temporal variability in urinary concentrations of phthalate metabolites, phytoestrogens and phenols among minority children in the United States. Environ Res 2007; 106(2):257-269.

8. Wolff MS. Endocrine disruptors: Challenges for environmental research in the 21st century. Ann NY Acad Sci 2006; 1076:228-238.

Environmental Tobacco Smoke

1. Best D, Committee on Environmental Health, Committee on Native American Child Health, Committee on Adolescence. From the American Academy of Pediatrics: Technical report--secondhand and prenatal tobacco smoke exposure. Pediatrics 2009; 124(5):1017-44.

2. Committee on Environmental Health, Committee on Substance Abuse, Committee on Adolescence, Committee on Native American Child. From the American Academy of Pediatrics: Policy statement--tobacco use: A pediatric disease. Pedatri 2009;124(5):1474-87.

3. Ehrlich RI, Kattan M, Saltzberg DS, Grimm KT, Landrigan PJ, Lilienfeld DE. Passive smoking and urinary cotinine levels in acute and non-acute asthmatics. Proceedings of the American Pediatric Society/Society for Pediatric Research;1990.

4. Ehrlich R, Kattan M, Godbold J, Saltzberg D, Grimm K, Landrigan PJ, Lilienfeld D. Childhood asthma and passive smoking: Urinary cotinine as a biomarker of exposure. Am Rev Respir Dis 1992; 145:594-599.

5. Landrigan PJ, DiLiberti JH, Graef JW, Hanson JW, Nathenson G. American Academy of Pediatrics. Involuntary smoking--a hazard to children. Committee on Environmental Hazards. Pediatrics 1986; 77:755-757.

6. Landrigan PJ, Etzel R. Chemical pollutants. In: Behrman R, editor. Nelson Textbook of Pediatrics. 16th ed. Philadelphia: WB Saunders Co; 1998.

7. Landrigan PJ, Gehlbach SH, Graef JW, Hanson JW, Nathenson G. Smokeless tobacco - A carcinogenic hazard to children. Committee on Environmental Hazards. Pediatrics 1985; 76:1009-1011.

8. Rinsky RA, Landrigan PJ. The contribution of epidemiology to the development of disease prevention policy. Arlington, VA: National Legal Center for the Public Interest; 1983.

Environmental Justice

1. Britton JA, Wolff MS, Lapinski R, Forman J, Hochman S, Kabat GC, Godbold J, Larson S, Berkowitz GS. Characteristics of pubertal development in a multi-ethnic population of nine-year-old girls. Ann Epidemiol 2004; 14(3):179-87.

2. Flores G, Fuentes-Afflick E, Barbot O, Carter-Pokras O, Claudio L, Lara M, McLaurin JA, Pachter L, Ramos-Gomez FJ, Mendoza F, Valdez RB, Villarruel AM, Zambrana RE, Greenberg R, Weitzman M. The health of Latino children: Urgent priorities, unanswered questions, and a research agenda. JAMA 2002 Jul 3; 288(1):82-90.

3. Galvan-Portillo MV, Wolff MS, Torres-Sánchez LE, López-Cervantes M, López-Carrillo L. Assessing phytochemical intake in a group of Mexican women. Salud Publica Mex 2007; 49:126-131.

4. Galvez MP, Morland K, Raines C, Kobil J, Siskind J, Godbold J, Brenner B. Race and food store availability in an inner-city neighborhood. Public Health Nutr 2007 Oct.

5. Lightdale J, Oken E, Klein W, Landrigan PJ, Welty T. Psychosocial barriers to health promotion in a American Indian population. American Indian and Alaska Native Mental Health 1995; 7:34-39.

6. Stein CR, Wortely PM, Singleton JA. Racial/ethnic disparities in influenza and pneumococcal vaccination levels among persons aged >65 years - United States. MMWR 2003; 52(40):958 - 962.

 

 

Ethylene Glycol

1. Levin SM, Landrigan PJ. Tollbooth syndrome. New York Times.

Ethylene Oxide

1. Landrigan PJ. Ethylene oxide. In: Rom WN, editor. Environmental and Occupational Medicine. 2nd ed. Boston: Little, Brown and Company; 1992.

2. Landrigan PJ. Occupational leukemia. State of the Art Reviews 1987; 2:179-188.

3. Landrigan PJ, Meinhardt TJ, Gordon J, Lipscomb JA, Berg JR, Mazzuckelli LR, Lewis TR, Lemen RA. Ethylene oxide: An overview of toxicologic and epidemiologic research. Am J Ind Med 1984; 6:103-116.

Formaldehyde

1. Landrigan PJ. Formaldehyde. In: Rom WN, editor. Environmental and Occupational Medicine. 2nd ed. Boston: Little, Brown & Company; 1992.

2. Landrigan PJ. Does formaldehyde cause cancer? A review of the evidence. Health and Environ Digest 1989; 3:1-3.

3. Landrigan PJ. Critical review of epidemiology studies on the human carcinogenicity of formaldehyde. Proceedings of the Annual Meeting of the Collegium Ramazzini; December 1, 1988.

4. Landrigan PJ, Golden AL, Markowitz SB. Occupational cancer in New York City firefighters. New York: United Firefighters Association and United Fire Officers Association; 1994.

5. Landrigan PJ, Perera FP. Controversy in the regulation of formaldehyde (editorial). Am J Ind Med 1988; 14:375-377.

6. Nelson N, Levine RJ, Albert RE, Blair AE, Griesemer RA, Landrigan PJ, Stayner LT, Swenberg JA. Contribution of formaldehyde to respiratory cancer. Environ Health Perspect 1986; 70:23-25.

Gasoline

1. Graber LK, Asher D, Anandaraja N, Bopp RF, Merrill K, Cullen MR, Luboga S, Trasande L. Childhood lead exposure after the phaseout of leaded gasoline: An ecological study of school-age children in Kampala, Uganda. Environ Health Perspect 2010; 118(6):884-889.

2. Landrigan PJ. The worldwide problem of lead in petrol. Bull WHO 2002; 80(10):768.

3. Landrigan PJ, DiLiberti JH, Gehlbach SH, Graef JW, Hanson JW, Jackson RJ, Nathenson G. Statement on childhood lead poisoning. American Academy of Pediatrics, Committee on Environmental Hazards, Committee on Accident and Poison Prevention. Pediatrics; 79: 457-465.

4. Needleman HL, Landrigan PJ. Toxins at the pump. New York Times Op-Ed.

General Children's Environmental Health

2. Brown RC, Bullock MB, Landrigan PJ, Sonawane B. Children's environmental health: Issues and challenges. In: Sonawane B, Brown R, editors. Encyclopedia of environmental health. Elsevier Ltd.; 2008.

3. Carpenter DO, Chew FT, Damstra T, Lam LH, Landrigan PJ, Makalinao I, Peralta GL, Suk WA. Environmental threats to the health of children: The Asian perspective. Environ Health Perspect 2000; 108:989-992.

4. Committee on Environmental Health, Tester JM. The built environment: Designing communities to promote physical activity in children. Pedatri 2009; 123(6):1591-8.

5. Edwards ES, Green N, Henry CJ, Landrigan PJ, Swartz D. Tracking children's health to age 21. Science 2003; 392:781.

6. Eskenazi B, Landrigan PJ. Environmental health perspects and children's environmental health. (editorial). Environ Health Perspect 2002; 110:A559-A560.

7. Galvez M, Forman J, Landrigan PJ. Children. In: Frumkin H, editor. Environmental Health: From Global to Local. Second Edition ed.; 2009.

8. Galvez M, Forman J, Landrigan PJ. Children. In: Frumkin H, editor. Environmental Health: From Global to Local; 2005.

9. Garg A, Landrigan PJ. Children's environmental health: New gains in science and policy. Ann Am Acad Pol Soc Sci 2002; 584:135.

10. Grandjean P, Landrigan PJ. Developmental neurotoxicity of industrial chemicals. Lancet 2006; 368(9553): 2167-2178.

11. Evidence of disproportionate increase in the use of tympanostomy tubes in US children: 1996 to 2006. Pediatric Academic Societies; May 2009.

12. Landrigan PJ. The unique vulnerability of the developing human brain to early neurotoxic exposures. In: The sixth princess chulabhorn international science congress: The interface of chemistry and biology in the "omics" era: Environment & health and drug discovery. Amarin Printing and Publishing Public Company Limited.

13. Landrigan PJ. Our most vulnerable. In: Cavoukian R, S. Olfman, editors. Child Honoring. How to Turn this World Around. Praeger Publishers; 2006.

14. Landrigan PJ. Environmental exposures and children's health challenges. Zero to Three 2005; 26: 8-10.

15. Landrigan PJ. Children as a vulnerable population. Int J Occup Med Environ Health 2004; 17:175-177.

16. Landrigan PJ. Environmental factors and pediatric disease: New developments in research and education. J San Francisco Medical Society 2004; 77:18.

17. Landrigan PJ. Why pollutants harm kids. The CHEC Report 2003; Fall 2003(12).

18. Landrigan PJ. Children's environmental health: An overview. Washington DC; 2001.

19. Landrigan PJ. Children's environmental health: Lessons from the past and prospects for the future. Pediatr Clin North Am 2000; 108:803.

20. Landrigan PJ. Children's health and the environment. Eur J Oncol 1999; 4:661-664.

21. Landrigan PJ. Mount Sinai to tackle children's environmental health issues. ACPM Newsletter (Spring 1999).

22. Landrigan PJ. The impact of environmental toxins on children's learning and behavior. The Aspen Institute Congressional Program; May 6, 1999.

23. Landrigan PJ. Environmental hazards for children. Report of the Twenty-Seventh Ross Roundtable on Critical Approaches to Common Pediatric Problems in collaboration with the Ambulatory Pediatric Association. Environmental health; November 19, 1996. Int J Occup Med and Environ Health 1998; 11:189-194.

24. Landrigan PJ. Risk assessment for children and other sensitive populations. Collegium Ramazzini Conference on Risk Assessment; Sept. 25-26, 1998.

25. Landrigan PJ. Risk assessment, risk management, and right to know - the three R's of child-centered environmental health policy. 124th Annual Meeting of the American Public Health Association; November 1996.

26. Landrigan PJ Carlson JE. Environmental policy and children's health. Future Child 1995; 5:34-52.

27. Landrigan PJ, Carlson JE, Bearer CF, Cranmer JS, Bullard RD, Etzel RA, Groopman J, McLachlan JA, Perera FP, Reigart JR, Robison L, Schell L, Suk WA. Children's health and the environment: A new agenda for prevention research. Environ Health Perspect 1998; 106:787-793.

28. Landrigan PJ, Etzel R. Children. In: Hashimoto D, Atkins S, Christiani D, Davis A, Leiken J, editor. Primary care guide to occupational and environmental medicine. St. Louis: Mosby; 1998.

29. Landrigan PJ, Garg A. Chronic effects of toxic environmental exposures on children's health. presented at the WHO/AAPCC Symposium on Children's Health and Environmental Toxicology: New Challenges for Toxicologists and Poison Centers. Montréal, Canada. Clin Toxicol 2002; 40:449-456.

30. Landrigan PJ, Garg A. Vulnerable populations. In: McCally M, editor. Life Support: the Environment and Human Health. Cambridge, Massachusetts: The MIT Press; 2002.

31. Landrigan PJ, Goldman L. Another view of children's health. Chemical and Engineering News 2003; 81:3.

32. Landrigan PJ, Kimmel CA, Correa A, Eskenazi B. Children's health and the environment: Public health issues and challenges for risk assessment. Environ Health Perspect 2003; 112:257-265.

33. Landrigan PJ, Needleman HL. Environmental neurotoxins and children's development. NCJW Journal 1997; 20:22-27.

34. Landrigan PJ, Tamburlini G. Children's health and the environment: A transatlantic dialogue. Environ Health Perspect 2005; 113:A646.

35. Landrigan PJ, Woolf AD, Gitterman B, Lanphear B, Forman J, Karr C, Moshier EL, Godbold J, Crain E. The ambulatory pediatric association fellowship in pediatric environmental health: A 5-year assessment. Environ Health Perspect 2007; 115:1383-1387.

36. Landrigan PJ. Children's health and the environment--the first Herbert L. Needleman award lecture. Maternal and Child Health Journal 1997;1:61-64.

37. Landrigan PJ, Forman JA. Chemical pollutants. In: Kliegman, Behrman, Jenson, Stanton, editors. Nelson Textbook of Pediatrics. 18th Edition ed. Saunders Elsevier Inc.; 2007.

38. Landrigan PJ, Garg A. Children are not little adults. In: Pronczuk - Garbino J, editor. WHO handbook on children's health and the environment. World Health Organization; 2005.

39. Landrigan PJ, Kotelchuck D, Grandjean P. Principles for the prevention of the toxicity of metals. In: Nordberg GF, Fowler BA, Nordberg M, Friberg LT, editors. Handbook of Toxicity of Metals. Academic Press, Inc.; 2007.

40. Landrigan PJ, Newman B. Children and other high-risk workers as a special challenge to occupational health services. SJWEH 2005; Suppl 1:43.

41. Landrigan PJ, Rauh VA, Galvez MP. Environmental justice and the health of children. Mount Sinai J Med 2010;77: 178-187.

42. Landrigan PJ, Sonawane B, Mattison D, McCally M, Garg A. Chemical contaminants in breast milk and their impacts on children's health. Environ Health Perspect 2002; 110:A313.

43. Landrigan PJ, Trasande L. More kids chronically ill. Poughkeepsie Journal. January 2, 2005.

44. Landrigan PJ, Trasande L. Applying precautionary principle in environmental risk assessment to children. In: Martuzzi M, Tickner JA, editors. The Precautionary Principle: Protecting Public Health, the Environment and the Future of our Children; 2004.

45. Landrigan PJ, Suk W, Amler R. Chemical wastes, children's health and the superfund basic research program. Environ Health Perspect 1999; 107:423-427.

46. Miodovnik A, Diplas AI, Engel SM, Zhu C, Chen J, Wolf MS. Pro-estrogenic polymorphisms and male-type behaviors in childhood. In Submission .

47. Pirisi A, Landrigan PJ: Children's health crusader. Lancet 2005; 365:1301.

48. Sonawane B, Landrigan PJ, Olin S. Children's environmental health risk assessment: Issues and challenges. Presented at the Society of Risk Assessment 2001.

49. Suk WA, Ruchirawat KM, Balakrishnan K, Berger M, Carpenter D, Damstra T, deGarbino Pronczuk J, Koh D, Landrigan PJ, Makalinao I, Sly PD, Xu Y, Zheng BS. Environmental threats to Children's health in Southeast Asia and the Western Pacific. Environ Health Perspect 2003; 111:1340.

50. Trasande L. Book review: Environmental health and child survival: Epidemiology, economics, experiences. Environ Health Perspect 2009; 117(10):A464.

51. Trasande L, Graber N, Landrigan PJ. Does New York State need a system of referral centers for children with environmental health concerns? Pediatric Academic Societies meeting; May 2005.

52. Trasande L, Landrigan PJ. Children away from chemicals. Poughkeepsie Journal.

53. Trasande L, Schechter C, Falk R, Graber N, Boscarino J, Dunkel G, Geslani J, Kaplan-Liss E, Moline J, Miller RK, Korfmacher K, Carpenter D, Balk SJ, Laraque D, Landrigan PJ. Could children's environmental health clinics be cost-effective? Public Health Association meeting; November 2006.

54. Weiss B, Landrigan PJ. The developing brain and the environment: An introduction. Environ Health Perspect 2000; 108:373-374.

55. Wilson R, Lovejoy FH, Jaeger RJ, Landrigan PJL. Acute phosphine poisoning aboard a grain freighter. Epidemiologic, clinical, and pathological findings. JAMA 1980; 244:148-150.

56. Wolff MS, Landrigan PJ. Organochlorine chemicals and children's health. (editorial). J Pediatr 2002; 140:10.

 

 

Gulf War Syndrome

1. Joellenbeck L, Landrigan PJ, Larson E. Gulf War veterans' illnesses: A case study in causal inference. Environ Res 1998;79:71-81.

2. Landrigan PJ. Is Gulf War syndrome due to stress? The evidence reexamined. Am J Epidemiol 1998; 148:404-405.

3. Landrigan PJ. Illness in gulf war veterans: Causes and consequences. The Journal of the American International Health Council 1998; 1:49-51.

4. Landrigan PJ. Illness in Gulf War veterans: Causes and consequences. JAMA 1997; 277:259-261.

5. Landrigan PJ. Identification of Gulf War syndrome: Methodological issues and medical illnesses. (letters in reply). JAMA 1997; 278:383-387.

6. Landrigan PJ, Lashof JC, Hamburg DA. Gulf war syndrome illness in veterans. (letter). Am J Epidemiol 1998; 148:404-407.

Heart Disease

1. Herbert R, Schechter C, Smith D, Phillips R, Diamond J, Carrol S, Weiner J, Dahms T, Landrigan PJ. Occupational coronary heart disease among bridge and tunnel officers. Arch Environ Health 2000; 55:152-163.

2. Landrigan PJ, Claudio L. Heart rate variability: A new physiologic marker of autonomic neurotoxicity. J Pediatrics 1997; 130:725-729.

3. Landrigan PJ, Morland K., and M. La Merrill. Environment and heart disease. In: Hurst's the Heart. 13th ed. Columbus, OH: McGraw-Hill; 2010.

4. Murata K, Landrigan PJ, Araki S. Effects of age, heart rate, gender, tobacco and alcohol ingestion on RR interval variability in human ECG.  J Autonomic Nervous System 1992; 37:199-206.

5. Smith D, Herbert R, Schechter C, Phillips R, Diamond J, Dahms TE, Landrigan PJ. Occupational coronary heart disease among bridge and tunnel officers. Can J Cardiology 1997; 13 (Supplement B):76B.

6. Smith D, Herbert R, Schechter C, Phillips R, Diamond J, Dahms TE, Landrigan PJ. Occupational coronary heart disease among bridge and tunnel officers. (poster). Fourth International Conference on Preventive Cardiology; June 1997; 1997.

7. Smith DA, Ness EM, Herbert R, Schechter CB, Phillips RA, Diamond JA, Landrigan PJ. Abdominal diameter index: A more powerful anthropometric measure for prevalent coronary heart disease risk in adult males. Diabetes, Obesity & Metabolism 2005; 4:370-380.

8. Smith D, Herbert R, Schechter C, Phillips R, Diamond J, Carrol S, Weiner J, Dahms T, Landrigan PJ. Occupational coronary heart disease among bridge and tunnel officers. Canadian J Cardiol 1997; 76(B).

Lead

1. Baker EL Jr, Hayes CG, Landrigan PJ, Handke JL, Leger RT, Housworth WJ, Harrington JM. A nationwide survey of heavy metal absorption in children living near primary copper, lead, and zinc smelters. Am J Epidemiol 1977; 106:261-273.

2. Baker EL Jr, Landrigan PJ, Barbour AG, Cox DH, Folland DS, Ligo RN, Throckmorton J. Occupational lead poisoning in the United States: Clinical and biochemical findings related to blood lead levels. Br J Ind Med 1979; 36:314-322.

3. Baker EL, Folland DS, Taylor TA, Frank M, Peterson W, Lovejoy G, Cox D, Housworth J, Landrigan PJ. Lead poisoning in children of lead workers: Home contamination with industrial dust. New Engl J Med 1977; 296:260-261.

4. Bandeen-Roche K, Glass TA, Bolla KI, Todd AC, Schwartz BS. Cumulative lead dose and cognitive function in older adults. Epidemiology 2009; 20(6):831-839.

5. Barthel W, Smrek A, Angel G, Liddle J, Landrigan PJ, Gehlbach S, Chrisholm J. Modified delves' cup atomic absorption determination of lead in blood.  J Official Analyst Chemists 1973; 56:1252-1256.

6. Bertin JE, Ashford NA, Bellinger D, Landrigan PJ, Legator MS, Mattison DR, McBeath WH, Rosen JF, Stellman JM. The goal: Safety and equality (editorial). Am J Ind Med 1992; 21:463-465.

7. Chisholm J, Goldstein G, Cory-Slechta D, Weiss B, Landrigan PJ, Mushak P, Needleman HL, Rice D, Rosen J, Silbergeld E. Lead debate goes on (letter). Pediatrics 1994;94:408-410.

8. Claudio L, Wetmur, JG, Landrigan PJ. Genetic susceptibility to lead neurotoxicity. 124th annual meeting of the American Public Health Association; November 1996.

9. Dorsey CD, Lee BK, Bolla KI, Weaver VM, Lee SS, Lee GS, Todd AC, Shi W, Schwartz BS. Comparison of patella lead with blood lead and tibia lead and their associations with neurobehavioral test scores. J Occup Environ Med 2006; 48(5):489-496.

10. Ehrlich R, Robins T, Jordaan E, Miller S, Mbuli S, Selby P, Wynchank S, Cantrell A, De Broe M, D'Haese P, Todd A, Landrigan PJ. Lead absorption and renal dysfunction in a South African battery factory. Occup Environ Med 1998; 55:453-460.

11. Etzel RA, Balk SJ, Reigart JR, Landrigan PJ. Environmental health for practicing pediatricians. Indian Pediatrics 2003:853.

12. Fewtrell LJ, Prüss-Ustün A, Landrigan PJ, Ayuso-Mateos JL. Estimating the global burden of disease of mild mental retardation and cardiovascular diseases from environmental lead exposure. Environ Res 2004; 94:120-133.

13. Fishbein DH, Todd AC, Ricketts EP, Semba RD. Relationship between lead exposure, cognitive function, and drug addiction: Pilot study and research age. Environ Res 2008; 108(3):315-319.

14. Galvez MP, Vanable L, Forman JA, Landrigan PJ, Akeredolu E, Leighton J, Nagin D. Childhood lead poisoning from commercially manufactured European ceramic dinnerware - New York City, 2003. MMWR 2004; 53:585.

15. Galvez MP, Vanable L, Forman JA, Landrigan PJ, Akeredolu E, Leighton J, Nagin D, Yip W, Simmonds K. A case of childhood lead poisoning from commercially manufactured European ceramic dinnerware, New York City, 2003. Annual Meeting of Pediatric Academic Societies; May 2004.

16. Ghosh-Narang J, Jones TM, Menke A, Todd AC, Muntner P, Batuman V. Parathyroid hormone status does not influence blood and bone lead levels in dialysis patients. Am J Med Sci 2007;334(6):415-420.

17. Glass TA, Bandeen-Roche K, McAtee M, Bolla K, Todd AC, Schwartz BS. Neighborhood psychosocial hazards and the association of cumulative lead dose with cognitive function in older adults. Am J Epidemiol 2009;169(6):683-692.

18. Glenn BS, Bandeen-Roche K, Lee BK, Weaver VM, Todd AC, Schwartz BS. Changes in systolic blood pressure associated with lead in blood and bone. Epidemiology 2006; 17(5):538-544.

19. Goldman L, Falk H, Landrigan PJ, Balk SJ, Reigart JR, Etzel RA. Environmental pediatrics and its impact on government health policy. Pediatrics 2004; 113:1146-1157.

20. Graber LK, Asher D, Anandaraja N, Bopp RF, Merrill K, Cullen MR, Luboga S, Trasande L. Childhood lead exposure after the phaseout of leaded gasoline: An ecological study of school-age children in Kampala, Uganda. Environ Health Perspect 2010; 118(6):884-889.

21. Greenberg A, Parkinson DK, Fetterolf DE, Puschett JB, Ellis KJ, Wielopolski L, Vaswani AN, Cohn SH, Landrigan PJ. Effects of elevated lead and cadmium burdens on renal function and calcium metabolism. Arch Environ Health 1986; 4:69-76.

22. Hetter KM, Bellis DJ, Geraghty C, Todd AC, Parsons PJ. Development of candidate reference materials for the measurement of lead in bone. Anal Bioanal Chem 2008; 391(6):2011-2021.

23. Landrigan PJ, Nordberg M, Lucchini R, Nordberg G, Grandjean P, Iregren A, Alessio L, International Workshop on Neurotoxic Metals: Lead, Mercury, and Manganese- From Research to Prevention (NTOXMET). The declaration of brescia on prevention of the neurotoxicity of metals. Am J Ind Med 2007; 50:709-711.

24. Landrigan PJ. Developmental neurotoxicity of industrial chemicals and pediatric bipolar disorder: A call to research. In: S. Olfman, editor. Bipolar Children. Praeger Publishers; 2007.

25. Landrigan PJ. The worldwide problem of lead in petrol. Bull WHO 2002; 80(10):768.

26. Landrigan PJ. Pediatric lead poisoning: Is there a threshold. Public Health Rep 2001; 115:530-531.

27. Landrigan PJ. Recent developments in the toxicology and epidemiology of lead. (in Japanese). Journal Public Hygiene 50 Years in Tokyo University 1997:45-47.

28. Landrigan PJ. Lead levels, home dust, and proximity to lead smelters (letter). Pediatrics 1996;97:603-604.

29. Landrigan PJ. Risk assessment and cost/benefit analysis for new regulations. New Solutions 1995; 5:85-91.

30. Landrigan PJ. Comments on a "Survey of lead exposure around a closed lead smelter." (letter). Pediatrics 1995; 95:550-554.

31. Landrigan PJ. Lead poisoning. In: Feldmann E, editor. Current diagnosis in neurology. St. Louis: Mosby-Year Book, Inc; 1994.

32. Landrigan PJ. Lead. In: Rosenstock L. Cullen M, editor. Textbook of Clinical Occupational and Environmental Medicine. 2nd ed. Philadelphia, London, Toronto, Montreal, Sydney, Tokyo: W.B. Saunders Company; 1994.

33. Landrigan PJ. Assessment of the health hazards of lead. In: LeVine DG, Upton AC, editors. Management of Hazardous Agents; 1992.

34. Landrigan PJ. Strategies for epidemiologic studies of lead in bone in occupationally exposed populations. Environ Health Perspect 1991; 91:81-86.

35. Landrigan PJ. Current issues in the epidemiology and toxicology of occupational exposure to lead (in Russian). Gigiena Truda 1991; 6:25-29.

36. Landrigan PJ. Current issues in the epidemiology and toxicology of occupational exposure to lead. Environ Health Perspect 1990; 89:61-66.

37. Landrigan PJ. Health effects of environmental toxins in deficient housing. Bull NY Acad Med 1990; 66:491-499.

38. Landrigan PJ. Proposal for reduction of the case definition for childhood lead poisoning. Proceedings of the 118th annual meeting of American public health association; 1990.

39. Landrigan PJ. Recent developments in the toxicology and epidemiology of lead. Tokyo J Med 1990; 97:170-172.

40. Landrigan PJ. The toxicity of lead at low dose. Br J Ind Med 1989; 46:593-596.

41. Landrigan PJ. Epidemiologic assessment of lead absorption associated with incineration of municipal waste. Proceedings of Annual Meeting of American Public Health Association; November 13-17 1988.

42. Landrigan PJ. Assessment of the health hazards of lead. Proceedings of a One Earth Forum on managing hazardous materials, René Dubos Center for Human Environments; May 25-26, 1988.

43. Landrigan PJ. Lead: Assessing its health hazards. Health and Environ Digest 1988;2:1-3.

44. Landrigan PJ. Principles for application of porphyrin markers in epidemiological studies. Ann NY Acad Sci 1987;514:323-326.

45. Landrigan PJ. The uses of epidemiology in the study of neurotoxic pollutants - lessons from the workplace. Int J Mental Health 1985; 14:44-63.

46. Landrigan PJ. Toxic exposures and psychiatric disease - lessons from the epidemiology of cancer. Acta Psychiatr Scand 1983; 67(303):6-15.

47. Landrigan PJ. Occupational and pediatric aspects of lead toxicity. Veterinary and Human Toxicology 1983; 25:1-6.

48. Landrigan PJ. Lead exposure, lead absorption and lead toxicity in the children of Port Pirie: A second opinion. Report to the minister of health of south Australia. Adelaide: 1983

49. Landrigan PJ. Lead study results questioned. Pediatrics 1982; 69:248.

50. Landrigan PJ. Occupational and community exposures to toxic metals - lead, cadmium, mercury and arsenic. Western J Med 1982; 137:532-539.

51. Landrigan PJ. Recent advances in the assessment of workplace exposure - epidemiologic linkage of medical and environmental data.  J Environ Sci Health 1982; A17:499-513.

52. Landrigan PJ. Increased lead absorption with anemia and slowed nerve conduction in children near a lead smelter. In: Proceedings of an International Workshop on Plans for Clinical and Epidemiologic Follow-up after Area-Wide Chemical Contamination. Washington, DC: National Academy of Sciences; 1982.

53. Landrigan PJ. Epidemiology of lead and other metal poisonings in children. In: Chemical and Radiation Hazards to Children. Report of the 84th Ross Conference on Pediatric Research. Columbus, Ohio: Ross Laboratories; 1982.

54. Landrigan PJ. Neurologic effects of exposure to lead. Peds 1978; 94:504-505.

55. Landrigan PJ. The exposure of children to lead from industry: Epidemiology and health consequences. In: Bertram W. Carnow M.D, editor. Proceedings of National Conference on Health Effects of Occupational Lead and Arsenic Exposure. Chicago, Illinois: U.S Department of Health, Education and Welfare; 1975.

56. Landrigan PJ, Baker D, Needleman HL. Lead poisoning in automobile radiator mechanics. New Engl J Med 1988; 318:320-321.

57. Landrigan PJ, Baker EL. Exposure of children to heavy metals from smelters: Epidemiology and toxic consequences. Environ Res 1981; 25:204-244.

58. Landrigan PJ, Baker EL. Occupational lead poisoning: Clinical and biochemical findings related to blood lead levels. Am J Epidemiol 1979;110:357.

59. Landrigan PJ, Baker EL. Reply to a note concerning the papers of Landrigan and associates. Peds 1977; 91:515.

60. Landrigan PJ, Baker EL Jr. Epidemiological aspects of occupational lead poisoning. J Univ Occup Environ Health 1983; 5:145-155.

61. Landrigan PJ, Baker EL Jr, Feldman RG, Cox DH, Eden KV, Orenstein WA, Mather JA, Yankel AJ, Von Lindern IH. Increased lead absorption with anemia and slowed nerve conduction in children near a lead smelter. J Pediatr 1976; 85:904-910.

62. Landrigan PJ, Baker EL Jr, Himmelstein JS, Stein GF, Weddig JP. Exposure to lead from the mystic river bridge: The dilemma of deleading. New Engl J Med 1982; 306:673-676.

63. Landrigan PJ, Baker EL, Whitworth RH, Feldman RG. Neuroepidemiologic evaluations of children with chronic increased lead absorption. In: Needleman HL, editor. Low Level Lead Exposure: The Clinical Implications of Current Research. New York: Raven Press; 1980.

64. Landrigan PJ, Boffetta P, Apostoli P. The reproductive toxicity and carcinogenicity of lead: A critical review. Am J Ind Med 2000; 38:231-243.

65. Landrigan PJ, Campbell CC. Chemical and physical agents. In: Sweet AY, Brown EG, editors. Fetal and neonatal effects of maternal disease. St. Louis: Mosby Year Book; 1991.

66. Landrigan PJ, Carter CD, Modlin FJ, Henderson RH, Edwards PQ. Lead absorption and slowed nerve conduction in children near a leadsmelter. Neurology 1976; 26:391-392.

67. Clark NL Landrigan PJ. Unions help reduce lead risk among workers. Forum for applied research and public policy; Summer; 1997.

68. Landrigan PJ, Curran A. Lead - A ubiquitous hazard. Environ Res 1992; 59:279-280.

69. Landrigan PJ, DiLiberti JH, Gehlbach SH, Graef JW, Hanson JW, Jackson RJ, Nathenson G. Statement on childhood lead poisoning. American Academy of Pediatrics, Committee on Environmental Hazards, Committee on Accident and Poison Prevention. Pediatrics; 79: 457-465.

70. Landrigan PJ, Earl JL, Chow TJ. Biogeochemical studies of lead isotopes near a smelter. October 20-23 1975; 1975.

71. Landrigan PJ Etzel R. Chemical pollutants. In: Behrman R, editor. Nelson Textbook of Pediatrics. 16th ed. Philadelphia: WB Saunders Co; 1998.

72. Landrigan PJ, Froines JR, Mahaffey KR. Body lead burden: A summary of epidemiological data on its relation to environmental sources and toxic effects. In: Mahaffey KR, editor. Dietary and Environmental Lead: Human Health Effects. Amsterdam: Elsevier Scientific Publishers; 1985.

73. Landrigan PJ, Gehlbach SH, Rosenblum BF, Shoults JM, Candelaria RM, Barthel WF, Liddle JA, Smrek AL, Staehling NW, Sanders JF. Epidemic lead absorption near an ore smelter. The role of particulate lead. New Engl J Med 1975; 292:123-129.

74. Landrigan PJ, Goyer RA, Clarkson TW, Sandler DP, Smith JH, Thun MJ, Weeden RP. The work-relatedness of renal disease. Arch Environ Health 1984; 39:225-230.

75. Landrigan PJ, Graef JW. Pediatric lead poisoning in 1987 - the silent epidemic continues. Pediatrics 1987; 719:582-583.

76. Landrigan PJ, Graham DG, Thomas RD. Strategies for the prevention of environmental neurotoxic illness. Environ Res 1993; 61:157-163.

77. Landrigan PJ, McKinney AS, Hopkins LC, Rhodes WW Jr, Price WA, Cox DH. Chronic lead absorption. Result of poor ventilation in an indoor pistol range. JAMA 1975; 234:394-397.

78. Rinsky RA, Landrigan PJ. The contribution of epidemiology to the development of disease prevention policy. Arlington, VA: National Legal Center for the Public Interest; 1983.

79. Landrigan PJ, Schechter CB, Lipton JM, Fahs MC, Schwartz J. Environmental pollutants and disease in American children: Estimates of morbidity, mortality, and costs for lead poisoning, asthma, cancer, and developmental disabilities. Environ Health Perspect 2002; 110:721-728.

80. Landrigan PJ, Silbergeld EK, Froines JR, Pfeffer RM. Lead in the modern workplace. Am J Public Health 1990; 80:907-908.

81. Landrigan PJ, Straub WE. Occupational lead exposure aboard a tall ship. Am J Ind Med 1985; 8:233-239.

82. Landrigan PJ, Todd AC. Lead poisoning alert--false alarm? (letter). West J Med 1995; 162:474-475.

83. Landrigan PJ, Todd AC. Lead poisoning. Conferences and reviews. Western J Med 1994; 161:153-159.

84. Landrigan PJ, Todd AC. Direct measurement of lead in bone: A promising biomarker. JAMA 1994; 271:239-240.

85. Landrigan PJ, Todd AC, Wedeen RP. Lead poisoning. Mt Sinai J Med 1995; 62:360-364.

86. Landrigan PJ, Whitworth RH, Baloh RW, Staehling NW, Barthel WF, Rosenblum BF. Neuropsychological dysfunction in children with chronic low-level lead absorption. Lancet 1975; 1:708-712.

87. Landrigan PJ, Whitworth RH, Feldman RG. Neurotoxicologic evaluations of children with chronic increased lead absorption. (abstract). March 4-7; 1979.

88. Landrigan PJ, Baker EL. Child health and environmental lead. Brit Med J 1977; 21:836.

89. Landrigan PJ, Baker EL. Increased lead absorption with anemia and subclinical neuropsychologic dysfunction in children near two lead smelters. October 27-31 1975; 1975.

90. Landrigan PJ, Houk VN. EPA review of lead study. Science 1984; 223:118.

91. Landrigan PJ, Slutsky J. Are learning disabilities linked to environmental toxins? Learning Disabilities Journal 2004; 15:7.

92. Landrigan PJ, Trasande L. Economic implication of metal neurotoxicity. Presented at an international workshop on neurotoxic metals: Lead mercury and manganese from research to prevention; June 17-18; 2006.

93. Laraque D, Trasande L. Lead poisoning: Successes and 21st century challenges. Pediatr Rev 2005; 26:435-443.

94. Levine RJ, Moore RM, McLaren GD, Barthel WF, Landrigan PJ. Occupational lead poisoning, animal deaths, and environmental contamination at a scrap smelter. Am J Public Health 1976; 66:548-552.

95. Marino PE, Franzblau A, Lilis R, Landrigan PJ. Acute lead poisoning in construction workers: The failure of current protective standards. Arch Environ Health 1989; 44:140-145.

96. Marino P, Landrigan PJ, Graef J, Nussbaum A, Bayan G, Boch K, Boch S. A case report of lead painting poisoning during renovation of a Victorian farmhouse. Am J Public Health 1990;80:1183-1185.

97. Markowitz SB, Li AK, Landrigan PJ. In: Reply: Lead poisoning due to hai ge fen. (letter). JAMA 1995; 273:24-25.

98. Markowitz S, Nuez C, Klizman S, Munshi A, Kim, WS, Eisinger, J, Landrigan PJ. Lead poisoning due to hai ge fen. The porphyrin content of individual erythrocytes. JAMA 1994; 271:932-934.

99. Martin D, Glass TA, Bandeen-Roche K, Todd AC, Shi W, Schwartz BS. Association of blood lead and tibia lead with blood pressure and hypertension in a community sample of older adults. Am J Epidemiol 2006; 163(5):467-478.

100. McLaren GC, Barthel WF, Landrigan PJ. Screening for lead poisoning: Measurements and methodology. Pediatrics 1973; 52:303.

101. Miller RW, Brent RL, Brown AK, Finberg L, Frantz C, Goldbloom VC, Heavenrich RM, Peebles TC, Stevenson JL, Jr., Falk H, Knelson JH, Landrigan PJ, Rogan, WJ. American Academy of Pediatrics. Committee on Environmental Hazards. National Standard for Airborne Lead. Peds 1978; 62:1070-1071.

102. Miodovnik A, Landrigan PJ. The FDA's risk assessment on lead in women's and children's vitamins is based on outdated assumptions. Environ Health Perspect 2009; 17:1021.

103. Moline J, Landrigan PJ. Lead. In: Rosendstock L, Cullen M, Brodkin D, Redlich C, editor. Textbook of Occupational and Environmental Medicine. 2nd Edition ed.

104. Morse DL, Landrigan PJ, Rosenblum BF, Hubert JS, Housworth J. El Paso revisited. epidemiologic follow-up of an environmental lead problem. JAMA 1979; 242:739-741.

105. Morse DL, Watson WN, Housworth J, Witherell LE, Landrigan PJ. Exposure of children to lead in drinking water. Am J Public Health 1979; 69:711-712.

106. Muntner P, Menke A, Batuman V, Rabito FA, He J, Todd AC. Association of tibia lead and blood lead with end-stage renal disease: A pilot study of African-Americans. Environ Res 2007; 104(3):396-401.

107. Needleman HL, Landrigan PJ. The health effects of low level exposure to lead. Am J Ind Med 1981; 2:277-298.

108. Needleman HL, Rosen J, Piomelli S, Landrigan PJ, Graef J. The hazards of benign neglect of elevated blood lead levels. Am J Dis Child 1987;141:941-942.

109. Needleman HL, Landrigan PJ. What level of lead in blood is toxic for a child?. Am J Public Health 2004; 94:8.

110. Onalaja AO, Claudio L. Genetic susceptibility to lead poisoning. Environ Health Perspect 2000 March 2000; 108(Suppl 1):23-28.

111. Schafer JH, Glass TA, Bressler J, Todd AC, Schwartz BS. Blood lead is a predictor of homocysteine levels in a population-based study of older adults. Environ Health Perspect 2005; 113(1):31-35.

112. Schwartz J, Landrigan PJ, Feldman RG, Silbergeld EK, Baker EL Jr, von Lindern IH. Threshold effect in lead-induced peripheral neuropathy. Pedatri 1988; 112:12-17.

113. Schwartz J, Landrigan PJ, Baker EL Jr, Orenstein W, VonLinder I. Lead induced anemia: Dose-response relationships and evidence for a threshold. Am J Public Health 1990;80:165-168.

114. Selevan SG, Landrigan PJ, Stern FB, Jones JH. Lead and hypertension in a mortality study of lead smelter workers. Environ Health Perspect 1988; 78:65-66.

115. Selevan SG, Landrigan PJ, Stern FB, Jones JH. Mortality of lead smelter workers. Am J Epidemiol 1985; 122:673-683.

116. Silbergeld EK, Landrigan PJ, Froines JR, Pfeffer RM. The occupational lead standard: A goal unachieved, a process in need of repair. New Solutions 1991;1:20-30.

117. Steenland K, Selevan SL, Landrigan PJ. The mortality of lead smelter workers: And update. Am J Public Health 1992;82:1641-1644.

118. Tamblyn PB, Landrigan PJ, Nelson M, Kerndt P, Kronoveter K, Zack MM. Lead exposure in stained glass workers.  J Environ Pathology, Toxicology and Oncology 1990; 10:63-66.

119. Theppeang K, Glass TA, Bandeen-Roche K, Todd AC, Rohde CA, Links JM, Schwartz BS. Associations of bone mineral density and lead levels in blood, tibia, and patella in urban-dwelling women. Environ Health Perspect 2008; 116(6):784-790.

120. Theppeang K, Glass TA, Bandeen-Roche K, Todd AC, Rohde CA, Schwartz BS. Gender and race/ethnicity differences in lead dose biomarkers. Am J Public Health 2008; 98(7):1248-1255.

121. Todd AC, Landrigan PJ. X-ray fluorescence analysis of lead in bone. Environ Health Perspect 1993; 101:494-495.

122. Todd AC, Landrigan PJ, Bloch P. Workshop on the X-ray fluorescence of lead in bone: Conclusions, recommendations and summary. Neurotoxicology 1993; 14:145-154.

123. Todd AC, Wetmur JG, Moline JM, Godbold JH, Levin SM, Landrigan PJ. Unraveling the chronic toxicity of lead: An essential priority for environmental health. Environ Health Perspect 1996;104(1):141-146.

124. Todd AC, Carroll S, Landrigan PJ. Key issues in childhood lead exposure in the USA. Urban Health and Development Bulletin of the South African Medical Research Council 2001.

125. Trasande L. Book review: The great water lead pipe disaster. JAMA 2007; 297:1601-1602.

126. Trasande L, Landrigan PJ, Schechter CB Falk R. Environmental pollutants and disease in New York State's children: Estimates of morbidity, mortality and costs for lead poisoning, asthma, cancer and developmental disabilities. Eastern Society of Pediatric Research; March 5, 2005; 2005.

127. Weaver VM, Ellis LR, Lee BK, Todd AC, Shi W, Ahn KD, Schwartz BS. Associations between patella lead and blood pressure in lead workers. Am J Ind Med 2008; 51(5):336-343.

128. Weaver VM, Griswold M, Todd AC, Jaar BG, Ahn KD, Thompson CB, Lee BK. Longitudinal associations between lead dose and renal function in lead workers. Environ Res 2009; 109(1):101-107.

129. Weaver VM, Jaar BG, Schwartz BS, Todd AC, Ahn KD, Lee SS, Wen J, Parsons PJ, Lee BK. Associations among lead dose biomarkers, uric acid, and renal function in Korean lead workers. Environ Health Perspect 2005; 113(1):36-42.

130. Weaver VM, Lee BK, Todd AC, Ahn KD, Shi W, Jaar BG, Kelsey KT, Lustberg ME, Silbergeld EK, Parsons PJ, Wen J, Schwartz BS. Effect modification by delta-aminolevulinic acid dehydratase, vitamin D receptor, and nitric oxide synthase gene polymorphisms on associations between patella lead and renal function in lead workers. Environ Res 2006; 102(1):61-69.

131. Weaver VM, Lee BK, Todd AC, Jaar BG, Ahn KD, Wen J, Shi W, Parsons PJ, Schwartz BS. Associations of patella lead and other lead biomarkers with renal function in lead workers. J Occup Environ Med 2005; 47(3):235-243.

132. Weaver VM, Schwartz BS, Jaar BG, Ahn KD, Todd AC, Lee SS, Kelsey KT, Silbergeld EK, Lustberg ME, Parsons PJ, Wen J, Lee BK. Associations of uric acid with polymorphisms in the delta-aminolevulinic acid dehydratase, vitamin D receptor, and nitric oxide synthase genes in Korean lead workers. Environ Health Perspect 2005; 113(11):1509-1515.

133. Wielopolski L, Ellis KJ, Vaswani AN, Cohn SH, Greenberg A, Puschett JB, Parkinson DK, Fetterolf DE, Landrigan PJ. In vivo bone lead measurements: A rapid monitoring method for cumulative lead exposure. Am J Ind Med 1986; 9:221-226.

134. Winegar DA, Levy BS, Andrews JS Jr, Landrigan PJ, Scruton WH, Krause MJ. Chronic occupational exposure to lead: An evaluation of the health of smelter workers. J Occup Med 1977; 19:603-606.

Measles

1. Brandling-Bennett A, Landrigan PJ, Baker EL. Failure of vaccinated school children to transmit measles. JAMA 1973; 224:616-618.

2. Landrigan PJ. Can measles vaccine cause hearing loss? JAMA 1973; 219:92.

3. Landrigan PJ, Conrad JL. Current status of measles in the United States. J Infect Dis 1971; 124:620-622.

4. Landrigan PJ, Griesbach PH. Measles in previously vaccinated children in Illinois. Illinois Med J 1972; 141:367-372.

5. Landrigan PJ, Murphy KB, Meyer HM Jr, Parkman PD, Eddins DL, Witte JJ. Combined measles-rubella vaccines. Virus dose and serologic response. Am J Dis Child 1973; 125:65-67.

6. Landrigan PJ, Rivas EN, Eddins DL. Epidemiologic assessment of a nationwide multiple antigen vaccine campaign. J Trop Pediatr 1974; 20:135-140.

7. Landrigan PJ. Epidemic measles in a divided city. JAMA 1972; 221:567-570.

8. Marshall R, Habicht JP, Landrigan PJ, Foege WH, Delgado H. Effectiveness of measles vaccine given simultaneously with DTP. J Trop Pediatr 1974; 20:135-140.

9. Schluederberg A, Lamm SH, Landrigan PJ, Black FL. Measles immunity in children vaccinated before one year of age. Am J Epidemiol 1974; 97:402-409.

10. Wallace RB, Landrigan PJ, Smith EA, Pifer J, Teller B, Foster SO. Trial of a reduced dose of measles vaccine in Nigerian children. Bull WHO 1976; 53:361-364.

Mental Retardation

1. Claudio L, Kwa WC, Russell AL, Wallinga D. Testing methods for developmental neurotoxicity of environmental chemicals. Toxicol App Pharmacol 2000 April 1; 164(1):1-14.

2. Fewtrell LJ, Prüss-Ustün A, Landrigan PJ, Ayuso-Mateos JL. Estimating the global burden of disease of mild mental retardation and cardiovascular diseases from environmental lead exposure. Environ Res 2004; 94:120-133.

3. Landrigan PJ. Neurologic effects of exposure to lead. Peds 1978; 94:504-505.

4. Trasande L, Schechter CB, Haynes KA, Landrigan PJ. Mental retardation and prenatal methylmercury toxicity. Am J Ind Med 2006:153-158.

5. Trasande L, Schechter CB, Haynes KA, Landrigan PJ. Social costs of mental retardation associated with methylmercury exposure in America. American Pediatric Academic Societies Meeting; May 2005.

Mercury

1. Bienenfeld LA, Golden AL, Garland EJ. Consumption of fish from polluted waters by WIC participants in East Harlem. J Urban Health 2003; 80(2):849-858.

2. Englender SJ, Atwood RG, Landrigan PJ, Clarkson TW, Greenwood MR, Smith JC. Organic mercury exposure from fungicide-contaminated eggs. Arch Environ Health 1980; 35:224-228.

3. Forman J, Moline J, Cernichiari E, Sayegh S, Torres J, Landrigan M, Hudson J, Adel H, Landrigan PJ. A cluster of pediatric metallic mercury cases treated with meso-2,3-dimercaptosuccinic acid(DMSA). Environ Health Perspect 2000; 108:575-577.

4. Gobeille AK, Morland KB, Bopp RF, Godbold JH, Landrigan PJ. Body burdens of mercury in lower Hudson River area anglers. Environ Res 2006; 101:205-212.

5. Hassan A, Velasquez E, Belmar R, Coye M, Drucker E, Landrigan PJ, Michaels D, Sidel KB. Mercury poisoning in Nicaragua: A case study of the export of environmental and occupational health hazards by a multinational corporation. Int J Health Serv 1981; 11:221-226.

6. Landrigan PJ, Nordberg M, Lucchini R, Nordberg G, Grandjean P, Iregren A, Alessio L, International Workshop on Neurotoxic Metals: Lead, Mercury, and Manganese- From Research to Prevention (NTOXMET). The declaration of Brescia on prevention of the neurotoxicity of metals. Am J Ind Med 2007; 50:709-711.

7. Landrigan PJ. Developmental neurotoxicity of industrial chemicals and pediatric bipolar disorder: A call to research. In: S. Olfman, editor. Bipolar Children. Praeger Publishers; 2007.

8. Landrigan PJ. Exposure to dimethylmercury New Engl J Med 1998; 339:1243-1244.

9. Landrigan PJ. The uses of epidemiology in the study of neurotoxic pollutants - lessons from the workplace. Int J Mental Health 1985; 14:44-63.

10. Landrigan PJ. Toxic exposures and psychiatric disease - lessons from the epidemiology of cancer. Acta Psychiatr Scand 1983; 67(303):6-15.

11. Landrigan PJ. Occupational and community exposures to toxic metals - lead, cadmium, mercury and arsenic. Western J Med 1982; 137:532-539.

12. Landrigan PJ, Campbell CC. Chemical and physical agents. In: Sweet AY, Brown EG, editors. Fetal and Neonatal Effects of Maternal Disease. St. Louis: Mosby Year Book; 1991.

13. Landrigan PJ, Etzel R. Chemical pollutants. In: Behrman R, editor. Nelson Textbook of Pediatrics. 16th ed. Philadelphia: WB Saunders Co; 1998.

14. Landrigan PJ, Golden A, Berkowitz G, Wolff M, Godbold J. Body burdens of persistent pollutants in Hudson River anglers. Global Forum for Children's Environmental Health; 7-11 September 2001; 2001.

15. Landrigan PJ, Graham DG, Thomas RD. Strategies for the prevention of environmental neurotoxic illness. Environ Res 1993; 61:157-163.

16. Landrigan PJ, Goldman L. Prenatal methylmercury exposure in the Seychelles - 3rd reply. Lancet 2003; 362:666.

17. Landrigan PJ, Trasande L. Mercury in sushi. The New York Times January 28, 2008.

18. Landrigan PJ, Trasande L. Economic implication of metal neurotoxicity. Presented at an international workshop on neurotoxic metals: Lead mercury and manganese from research to prevention; June 17-18; 2006.

19. Landrigan PJ, Golden AL, Simpson HJ. Toxic substances and their impacts on human health in the Hudson River watershed. In: Levinton J, Waldman J, editors. The Hudson River Estuary. Cambridge University Press; 2006.

20. Trasande L, Boscarino J, Graber N, Falk R, Schechter C, Galvez M, Dunkel G, Geslani J, Moline J, Kaplan-Liss E, Miller RK, Korfmacher K, Carpenter D, Forman J, Balk SJ, Laraque D, Frumkin H, Landrigan PJ. The environment in pediatric practice: A study of New York pediatricians' attitudes, beliefs, and practices towards children's environmental health. J Urban Health 2006 Jul; 83(4):760-772.

21. Trasande L, Cortes JE, Landrigan PJ, Abercrombie MI, Bopp RF, Cifuentes E. Methylmercury exposure in a subsistence fishing community in Lake Chapala, Mexico: An ecological approach. Environ Health 2010; 9:1.

22. Trasande L, Landrigan PJ, Schechter C. Public health and economic consequences of methyl mercury toxicity to the developing brain. Environ Health Perspect 2005; 113:590-596.

23. Trasande L, Landrigan PJ, Schechter CB, Bopp RF. Methylmercury and the developing brain. Environ Health Perspect 2007; 115: A396-A397.

24. Trasande L, Schechter C, Haynes KA, Landrigan PJ. Applying cost analyses to drive policy that protects children: Mercury as a case study. Annals of the New York Academy of Sciences 2006; 1076:911-923.

25. Trasande L, Schechter CB, Haynes KA, Landrigan PJ. Mental retardation and prenatal methylmercury toxicity. Am J Ind Med 2006:153-158.

26. Trasande L, Schechter CB, Landrigan PJ. Cost-benefit analysis of policy options to reduce mercury pollution in America. American Public Health Association meeting; November 2006; 2006.

27. Trasande L, Schechter CB, Landrigan PJ, Haynes KA. Social costs of mental retardation associated with methylmercury exposure in America. Pediatric Academic Societies meeting; May 2005; 2005.

Mold

1. Trasande L, Boscarino J, Graber N, Falk R, Schechter C, Galvez M, Dunkel G, Geslani J, Moline J, Kaplan-Liss E, Miller RK, Korfmacher K, Carpenter D, Forman J, Balk SJ, Laraque D, Frumkin H, Landrigan PJ. The environment in pediatric practice: A study of New York pediatricians' attitudes, beliefs, and practices towards children's environmental health. J Urban Health 2006 2006 Jul; 83(4):760-772.

National Children's Study

1. Fenske RA, Bradman A, Whyatt RM, Wolff MS, Barr DB. Assessment of children's pesticide exposure: Critical sampling and analytical issues for future studies. Environ Health Perspect 2005; 113:1455-1462.

2. Goldman L, Falk H, Landrigan PJ, Balk SJ, Reigart JR, Etzel RA. Environmental pediatrics and its impact on government health policy. Pediatrics 2004; 113:1146-1157.

3. Landrigan PJ. Environmental threats to children's health - the promise of the National Children's Study. NECOEM Reporter; 2:1.

4. Landrigan PJ, Trasande L, Swanson JM. Genetics, altruism, and the National Children's Study. Am J of Med Genetics 2008; A (146A).

5. Landrigan PJ, Trasande L, Thorpe LE, Gwynn C, Lioy PJ, D'Alton ME, Lipkind HS, Swanson J, Wadhwa PD, Clark EB, Rauh VA, Perera FP, Susser E. The National Children's Study: A 21-year prospective study of 100,000 American children. Pediatrics 2006; 118(5):2173-2186.

6. Landrigan PJ, Garg A, Droller DBJ. Assessing the effects of endocrine disruptors in the National Children's Study. Environ Health Perspect 2003; 111:1678.

7. Lioy PJ, Isukapalli SS, Trasande L, Thorpe L, Dellarco M, Weisel C, Georgopoulos PG, Yung C, Alimokhtari S, Brown M, Landrigan PJ. Using national and local extant data to characterize environmental exposures in the National Children's Study: Queens County, New York. Environ Health Perspect 2009; 117:1494-1504.

8. Trasande L, Cronk C, Durkin M, Weiss M, Schoeller D, Gall E, Hewitt J, Carrel A, Landrigan PJ, Gillman M. Environment and obesity in the National Children's Study. Environ Health Perspect 2009; 117:159-166.

9. Trasande L, Cronk CE, Leuthner SR, Hewitt JB, Durkin MS, McElroy JA, Anderson HA, Landrigan PJ. The national children's study and the children of Wisconsin. Wisconsin Medical Journal 2006; 105(2):45-49.

10. Trasande L, Landrigan PJ. NIH announces vanguard centers for national Children's study. Ambulatory Pediatric Association Newsletter 2005; 41(2):19.

11. Trasande L, Landrigan PJ. The National Children's Study: A critical national investment. Environ Health Perspect 2004; 112:A789.

12. Community outreach and engagement in the National Children's Study Vanguard Centers. Pediatric Academic Societies meeting; May 2007; 2007.

Obesity

1. Cleveland RJ, Gammon MD, Long CM, Gaudet MM, Eng SM, Teitelbaum SL, Neugut AI, Santella RM. Common genetic variations in the LEP and LEPR genes, obesity and breast cancer incidence and survival. Breast Cancer Res Treat 2009; 120(3):745-52.

2. Committee on Environmental Health, Tester JM. The built environment: Designing communities to promote physical activity in children. Pedatri 2009; 123(6):1591-8.

3. Galvez M, Brenner B, Rivera M, Teitelbaum S, Moskowitz H, Claudio L, Berkowitz T, Wolff M, Forman J, Landrigan PJ. Exposure assessment of environmental risk factors for Overweight/Obesity in urban children. The annual meeting of pediatric academy societies; 2003.

4. Galvez MP, Frieden TR, Landrigan PJ. Obesity in the 21st century. Environ Health Perspect 2003; 111(13):A684-A685.

5. Galvez MP, Hong L, Choi E, Liao L, Godbold J, Brenner B. Childhood obesity and neighborhood food-store availability in an inner-city community. Acad Pediatr 2009; 9(5):339-43.

6. Galvez MP, Morland K, Raines C, Kobil J, Siskind J, Godbold J, Brenner B. Race and food store availability in an inner-city neighborhood . Public Health Nutr 2007 2007 Oct.

7. Galvez MP, Pearl M, Yen IH. Childhood obesity and the built environment. Curr Opin Pediatr 2010; 22(2):202-7.

8. Landrigan PJ, Droller DBJ. The burden of obesity among urban people. The Green Guide 2003:98.

9. Semenkovich CF, Teitelbaum SL. Bone weighs in on obesity. Cell 2007; 130(3):409-411.

10. Trasande L. How much should the US invest in childhood obesity prevention? Health Aff 2010; 29(3):372-378.

11. Trasande L. A clinical guide for management of overweight and obese children and adults. JAMA 2007; 298:463.

12. Trasande L, Chatterjee S. The impact of obesity on health service utilization and costs in childhood. Obesity (Silver Spring) 2009; 17(9):1749-1754.

13. Trasande L, Cronk C, Durkin M, Weiss M, Schoeller D, Gall E, Hewitt J, Carrel A, Landrigan PJ, Gillman M. Environment and obesity in the National Children's Study. Environ Health Perspect 2009; 117:159-166.

14. Trasande L, Lee M, Liu Y, Weitzman M, Savitz D. Incremental charges, costs, and length of stay associated with obesity as a secondary diagnosis among pregnant women. Med Care 2009; 47(10):1046-1052.

15. Trasande L, Liu Y, Fryer G, Weitzman M. Trends in U.S. hospitalizations, charges and costs associated with childhood obesity. Health Aff 2009; 28(4):751-760.

16. Trasande L, Schechter CB, Gillman MW, Burns TL, Savitz DA, Landrigan PJ. Projecting the burden of childhood obesity to 2030: Demographics and disparities. Pediatric Academic Societies meeting; May 2007.

Occupational Disease

1. Baker D, Landrigan PJ. Workers. In: Detels R, Holland WW, McEwen J, Omenn GS, editor. The Practice of Public Health. Oxford, New York, Toronto: Oxford University Press; 1997.

2. Baker DB, Landrigan PJ. Occupational exposures and human health. In: Chivian E., McCally M, Hu H, Haines A, editor. Critical Condition: Human Health and the Environment. Cambridge: MIT Press; 1993.

3. Baker DB, Landrigan PJ. Occupationally related disorders. Med Clin North Am 1990;74:441-460.

4. Bates DV, Gotsch AR, Brooks S, Landrigan PJ, Hankinson JL, Merchant JA. Prevention of occupational lung diseases. Chest 1992; 102 (Supplement): 257S-276S.

5. Brigham CR, Landrigan PJ. Safety and health in boat building and repair. Am J Ind Med 1985; 8:169-182.

6. Christiani DC, Melius JM, Landrigan PJ, Coye MJ, Wegman DH. Control of occupational disease in the U.S.A. (in Chinese). Chinese J Occup Health 1988; 4:314-320.

7. Fahs MC, Markowitz SB, Fischer E, Shapiro J, Landrigan PJ. Health costs of occupational disease in New York State. Am J Ind Med 1989; 16:437-449.

8. Gerr F, Letz R, Landrigan PJ. Upper-extremity musculoskeletal disorders of occupational origin. Ann Rev Pub Health 1991; 12:543-566.

9. Herbert R, Landrigan PJ. Work-related death: A continuing epidemic. Am J Public Health 2000; 90:541-545.

10. Herbert R, Landrigan PJ. When work is a health hazard. New York Newsday Op-ed.

11. Herbert RH, Luo J, Marcus M, Landrigan PJ. The failure of workers compensation statistics to monitor work-related illness in garment workers. Proceedings of Annual Meeting of the American Public Health Association; October 1989.

12. Herbert R, Plattus B, Kellogg L, Luo J, Marcus M, Mascolo A, Landrigan PJ. The union health center: A working model of clinical care linked to preventive occupational health services. Br J Ind Med 1997; 31:263-273.

13. Horan JM, Kurt TL, Landrigan PJ, Melius JM, Singal M. Neurologic dysfunction from exposure to 2-t-butylazo-2-hydroxy-5-methylhexane (BHMH): A new occupational neuropathy. Am J Public Health 1985; 75:513-517.

14. Johanning E, Wilder D, Landrigan PJ, Pope M. Whole-body vibration exposure in subway cars and review of adverse health effects.  J Occup Med 1991; 33:605-612.

15. Kraut A, Lilis R, Marcus M, Valciukas JA, Wolff MS, Landrigan PJ. Neurotoxic effects of solvent exposure on sewage treatment workers. Arch Environ Health 1988; 43:263-268.

16. Landrigan PJ, Pollack S, Godbold J, Belville R. Occupational injuries--epidemiology, prevention, treatment. Adolesc Med 1995; 6:207-214.

17. Landrigan PJ. Principles of occupational and environmental medicine. In: Ausiello D. Goldman L, editor. Cecil Textbook of Medicine. 22nd ed. Philadelphia: W.B. Saunders Co; 2003.

18. Landrigan PJ. Bernardino Ramazzini: Perpetuating the lesson of the master. the diagnosis and prevention of occupational and environmental illness. (editorial). Eur J Oncol 2001; 73:11-17.

19. Landrigan PJ. Principles of occupational and environmental medicine. In: Goldman L, editor. Cecil Textbook of Medicine. 21st ed. Philadelphia: W.B. Saunders Co; 2000.

20. Landrigan PJ. Foreword: Occupational and environmental medicine. In: Feldman RG, editor. Occupational and Environmental Neurotoxicology. Philadelphia-New York: Lippincott-Raven; 1998.

21. Landrigan PJ. Occupational illness (commentary). Abstracts of Clinical Care Guidelines 1996; 8:15-16.

22. Landrigan PJ. Principles of occupational and environmental medicine. In: Plum F. Bennet JC, editor. Cecil Textbook of Medicine. 20th ed. Philadelphia: WB Saunders Co.; 1994.

23. Landrigan PJ. Current status of occupational disease in the United States (editorial). J Occup Med Toxicol 1992; 1:97-100.

24. Landrigan PJ. Occupational surveillance -- needs and priorities. Occupational Surveillance Conference; April 29, 1991; 1991.

25. Landrigan PJ. Out sick, toxins at work. Harvard Medical Alumni Bulletin 1990; Summer 1990: 42-47.

26. Landrigan PJ. Improving the surveillance of occupational disease. Am J Public Health 1989; 79:1601-1602.

27. Landrigan PJ. Occupational health in New York State. Proceedings of the Julia M. Jones Preventive Medicine Day; October 18, 1989; 1989.

28. Landrigan PJ. Academic occupational health and environmental medicine: Current directions. Bull NY Acad Med 1985; 61:901-916.

29. Landrigan PJ. The importance of occupational cohorts in chronic disease epidemiology. NCI Monograph 1985; 67:83.

30. Landrigan PJ, Baker D. The clinical recognition of occupational and environmental disease. Mt Sinai J Med 1995; 62:406-411.

31. Landrigan PJ, Baker D. Using occupational history to pinpoint the diagnosis. Geriatrics 1991; 46:61-67.

32. Landrigan PJ, Baker D. The recognition and control of occupational disease. JAMA 1991; 266:676-680.

33. Landrigan PJ, Baker D. Workers, occupational health. In: Holland WW, Detels R, Knox G, editor. Oxford Textbook of Public Health. 2nd ed. Oxford, New York, Toronto: Oxford University Press; 1991.

34. Landrigan PJ, Kreiss K, Xintaras C, Feldman RG, Heath CW. Clinical epidemiology of occupational neurotoxic disease. Neurobehav Toxicol 1980; 2:43-48.

35. Landrigan PJ Markowitz S. Current magnitude of occupational disease in the United States. Estimates from New York State. Ann NY Acad Sci 1989; 572:27-45.

36. Landrigan PJ, Rinsky RA, Melius JM, Thun MJ. Approaches to the estimation of exposure in occupational and environmental epidemiology. Proceedings of the Banbury Center Conference on Risk Quantitation and Regulatory Policy; 1984.

37. Landrigan PJ, Robbins A. Foreward. In: Cherniack MG, editor. The Hawk's Nest Incident: America's Worst Industrial Disaster. New Haven: Yale University Press; 1986.

38. Landrigan PJ Selikoff IJ. Primary prevention against occupational carcinogens. In: Bannasch P, editor. Cancer Risks: Strategies for Elimination. Berlin, Heidelberg, New York, London, Paris, Tokyo: Springer-Verlag; 1987.

39. Leigh JP, Markowitz SB, Fahs F, Shin C, Landrigan PJ. Occupational injury and illness in the United States. Estimates of cost, morbidity, and mortality. Arch Intern Med 1997; 157: 1557-1568.

40. Markowitz S, Landrigan PJ. The magnitude of the occupational disease problem: An investigation in New York State. Toxicol Ind Health 1989; 5:9-30.

41. Markowitz SB, Landrigan PJ. Occupational lung disease: Diagnosis, surveillance, and prevention. Current Issues in Respiratory Public Health 1990; 3:219-232.

42. Melius JM, Landrigan PJ. Occupational health. In: Blumenthal DS, editor. Introduction to Environmental Health. New York; 1985.

43. Moody L, Halperin WE, Fingerhut MA, Landrigan PJ. The chronic health effects of occupational exposure to dioxins: Unanswered questions. Am J Ind Med 1984; 5:157-160.

44. Morse DL, Kominsky JR, Wisseman CL 3rd, Landrigan PJ. Occupational exposure to hexachlorocyclopentadiene. How safe is sewage? JAMA 1979; 241:2177-2179.

45. Osinubi OYO, Landrigan PJ. Book review: Occupational, industrial and environmental toxicology. Am J Ind Med 1998; 33:99.

46. Robbins A, Landrigan PJ. Safer, healthier workers: Advances in occupational disease and injury prevention. In: Warren C. Ward JW, editor. Silent Victories. Oxford University Press; 2007.

47. Schulte PA, Singal M, Stringer WT, Kominsky JR, Landrigan PJ. The efficacy of a population-based comparison group in cross-sectional occupational health studies. Am J Epidemiol 1982; 116:981-989.

48. Schwartz E, Landrigan PJ. Use of court records for supplementing occupational disease surveillance. Am J Public Health 1987; 77:1457-1458.

49. Solomon AJ, Doucette JT, Garland E, McGinn T. Healthcare and the long haul: Long distance truck drivers--a medically underserved population. Am J Ind Med 2004; 46(5):463-471.

50. Stein CR, Weber DJ, Kelley M. Using hospital antibiogram to assess regional pneumococcal resistance to antibiotics. Emerging Infectious Diseases 2003; 9(2):211-216.

51. Wilson R, Lovejoy FH, Jaeger RJ, Landrigan PJL. Acute phosphine poisoning aboard a grain freighter. Epidemiologic, clinical, and pathological findings. JAMA 1980; 244:148-150.

Ozone

1. Cifuentes E, Trasande L, Ramirez M, Landrigan PJ. A qualitative analysis of environmental policy and children's health in Mexico . Environ Health 2010; 9:14.

2. Landrigan PJ. Recent advances in the assessment of workplace exposure - epidemiologic linkage of medical and environmental data.  J Environ Sci Health 1982; A17: 499-513.

Pesticides

1. Berkowitz GS, Obel J, Deych E, Lapinski R, Godbold J, Liu Z, Landrigan PJ, Wolff MS. Exposure to indoor pesticides during pregnancy in a multiethnic, urban cohort. Environ Health Perspect 2003; 111: 79-84.

2. Bienenfeld LA, Golden AL, Garland EJ. Consumption of fish from polluted waters by WIC participants in East Harlem. J Urban Health 2003;80(2):849-858.

3. Brenner BL, Markowitz S, Rivera M, Romero H, Weeks M, Sanchez E, Deych E, Garg A, Godbold J, Wolff MS, Landrigan PJ, Berkowitz G. Integrated pest management in an urban community: A successful partnership for prevention. Environ Health Perspect 2003; 111: 1649-1653.

4. Cannon SB, Veazey JM Jr, Jackson RS, Burse VW, Hayes C, Straub WE, Landrigan PJ, Liddle JA. Epidemic kepone poisoning in chemical workers. Am J Epidemiol 1978; 107: 529-537.

5. Claudio L, Kwa WC, Russell AL, Wallinga D. Testing methods for developmental neurotoxicity of environmental chemicals. Toxicol App Pharmacol 2000 April 1; 164(1):1-14.

6. Cohn BA, Wolff MS, Cirillo PM, Sholtz RI. DDT and breast cancer in young women: New data on the significance of age at exposure Environ Health Perspect 2007; 115: 1406-1414.

7. Engel SM, Berkowitz GS, Barr DB, Teitelbaum SL, Siskind J, Meisel SJ, Wetmur JG, Wolff MS. Prenatal organophosphate metabolite and organochlorine levels and performance on the brazelton neonatal behavioral assessment scale in a multiethnic pregnancy cohort. Am J Epidemiol 2007; 165(12):1397-404.

8. Fenske RA, Bradman A, Whyatt RM, Wolff MS, Barr DB. Assessment of children's pesticide exposure: Critical sampling and analytical issues for future studies. Environ Health Perspect 2005; 113: 1455-1462.

9. Galson SK, Carroquino MJ, Landrigan PJ. Introduction to conference on preventable causes of cancer in children. Environ Health Perspect 1998; 106: 865-866.

10. Landrigan PJ. Counting roaches. Reducing pesticide exposures via integrated pest management. Med and the En 2010 (April): 32.

11. Landrigan PJ. Strong chemicals, strong action, strong control. The CHEC Report 2002(8).

12. Landrigan PJ. Foreword: Pest control in public housing, schools and parks: Urban children at risk. In: State of New York, Attorney General Eliot Spitzer. Environmental Protection Bureau; 2002.

13. Landrigan PJ. Pesticides, PCBs, and the risk to children. Contemporary Pediatrics 2001; 18(2):110-126.

14. Landrigan PJ. Malathion may be a necessary evil. Newsday Viewpoints.

15. Landrigan PJ. Pesticides. In: Etzel R, Balk S, editors. Handbook of Pediatric Environmental Health. Elk Grove, Illinois: American Academy of Pediatrics; 1999.

16. Landrigan PJ. Pesticides harm kids (letter to editor). New York Times letter to the editor.

17. Landrigan PJ. Illness in gulf war veterans: Causes and consequences. JAMA 1997; 277: 259-261.

18. Landrigan PJ. Pesticides in the diets of infants and children: The report from the National Academy of Sciences two years later. EPA Journal 1995.

19. Landrigan PJ. Perspective on pesticides. In: Encyclopedia Britannica, Medical and Health Annual; 1994.

20. Landrigan PJ. Protecting children from pesticides (letter). Washington Post Letter to the Editor.

21. Landrigan PJ. Arsenic. In: Rom WN, editor. Environmental and Occupational Medicine. Boston: Little, Brown and Co; 1983.

22. Landrigan PJ, Claudio L, McConnell R. Pesticides. In: Lippmann M, editor. Environmental Toxicants: Human Exposures and their Health Effects. New York: John Wiley & Sons, Inc; 2000.

23. Landrigan PJ, Claudio L, McConnell R. Pesticides. In: Lippmann M, editor. Environmental Toxicants-Human Exposures and their Health Effects. New York: Van Nostrand Reinhold; 1998.

24. Landrigan PJ, Golden A, Berkowitz G, Wolff M, Godbold J. Body burdens of persistent pollutants in Hudson River Anglers. Global Forum for Children's Environmental Health; 7-11 September 2001; 2001.

25. Landrigan PJ, Goldman LR. Response to the report of the Canadian ad hoc panel on pesticides and cancer risk. (Letter to the editor). Cancer 1998; 83: 1057-1058.

26. Landrigan PJ, Kreiss K, Xintaras C, Feldman RG, Heath CW. Clinical epidemiology of occupational neurotoxic disease. Neurobehav Toxicol 1980; 2: 43-48.

27. Landrigan PJ, McCally M, Oleskey C. Ethics of pesticide testing in humans. Environ Health Perspect 2003; 111: A750.

28. Landrigan PJ, Melius JM, Rosenberg MJ, Coye MJ, Binkin NJ. Reproductive hazards in the workplace: Development of epidemiologic research. Scand J Environ Health 1983; 9: 83-88.

29. Landrigan PJ. Pesticides and polychlorinated biphenyls (PCBs): An analysis of the evidence that they impair children's neurobehavioral development. Molecular Genetics and Metabolism 2001; 73: 11-17.

30. Landrigan PJ and Bullock M. Integrated pest management (IPM) can cost-effectively reduce pesticide exposures in the urban environment. Presented at Translating Science to Policy Protecting Children's Environmental Health; March 30, 2009.

31. Landrigan PJ, Claudio L. Pesticides. In: Lippmann M, editor. Environmental Toxicants: Human Exposures and their Health Effects. Third Edition ed. John Wiley & Sons; 2007.

32. Landrigan PJ, Claudio L. Pesticides. In: Lippmann M, editor. Environmental Toxicants: Human Exposures and their Health Effects. Third Edition ed. John Wiley & Sons; 2005.

33. Landrigan PJ, Claudio L. Pesticides. In: Lippmann, editor. Environmental Toxicants. Third Edition ed. John Wiley & Sons; 2009.

34. Landrigan PJ, Claudio L, Markowitz S, Berkowitz G, Brenner B, Romero H, Wetmur J, Matte T, Gore A, Godbold J, Wolff M. Pesticides and inner-city children: Exposures, risks, and prevention. Environ Health Perspect 1999; 107(3):431-437.

35. Landrigan PJ, Golden AL, Simpson HJ. Toxic substances and their impacts on human health in the Hudson River watershed. In: Levinton J, Waldman J, editors. The Hudson River Estuary. Cambridge University Press; 2006.

36. Louis ED, Factor-Litvak P, Parides M, Andrews L, Santella RM, Wolff MS. Organochlorine pesticide exposure in essential tremor: A case-control study using biological and occupational exposure assessments. Neurotoxicol 2006; 27: 579-586.

37. Miodovnik A and Wolff MS. Chapter on prenatal exposure to industrial chemicals and pesticides and effects on neurodevelopment. In: Elsevier Ltd; 2010.

38. Moline JM, Golden AL, Bar-Chama N, Smith E, Rauch ME, Chapin RE, Perreault SD, Schrader SM, Suk WA, Landrigan PJ. Exposure to hazardous substances and male reproductive health: A research framework. Environ Health Perspect 2000; 108: 803-813.

39. Morland K, Wolff M, Bopp R, Godbold J, Landrigan PJ. Fish consumption and body burden of organochlorines among lower Hudson urban anglers. Am J Ind Med 2008; 51: 587-594.

40. Morse DL, Baker EL, Landrigan PJ. Cut flowers: A potential pesticide hazard. Am J Public Health 1979;69:53-56.

41. Patton RM, Arthur T, Bain EI, Balbus J, Landrigan PJ. Open letter to Stephen Johnson, administrator, U.S. Environmental Protection Agency: Ban endosulfan. Int J Ocupp and Environ Health 2008; 14: 236.

42. Pollack S, McConnell R, Gallelli M, Schmidt J, Obregon R, Landrigan PJ. Pesticide exposure and working conditions among migrant farmworker children in western New York State. Proceedings of the 118th annual meeting of American Public Health Association; 1990; 1990.

43. Teitelbaum SL, Gammon MD, Britton JA, Neugut AI, Levin B, Stellman SD. Reported residential pesticide use and breast cancer risk on Long Island, New York. Am J Epidemiol 2006; 165(6):643-51.

44. Torres-Sánchez L, Rothenberg SJ, Schnaas L, Cebrián ME, Osorio E, Del Carmen Hernández M, García-Hernández RM, Del Rio-Garcia C, Wolff MS, López-Carrillo L. In utero p,p'-DDE exposure and infant neurodevelopment: A perinatal cohort in Mexico. Environ Health Perspect 2007; 115:435-539.

45. Trasande L, Boscarino J, Graber N, Falk R, Schechter C, Galvez M, Dunkel G, Geslani J, Moline J, Kaplan-Liss E, Miller RK, Korfmacher K, Carpenter D, Forman J, Balk SJ, Laraque D, Frumkin H, Landrigan PJ. The environment in pediatric practice: A study of New York pediatricians' attitudes, beliefs, and practices towards children's environmental health. J Urban Health 2006 2006 Jul; 83(4):760-772.

46. Wolff MS. Endocrine disruptors: Challenges for environmental research in the 21st century. Ann NY Acad Sci 2006; 1076: 228-238.

47. Wolff MS, Anderson HA, Britton JA, Rothman N. Pharmacokinetic variability and modern Epidemiology-The example of dichlorodiphenyltrichloroethane, body mass index, and birth cohort. Cancer Epidemiol Biomarkers Prev 2007; 16: 1925-1930.

48. Wolff MS, Britton JA, Boguski L, Hochman S, Maloney N, Serra N, Liu Z, Berkowitz G, Larson S, Forman J. Environmental exposures and puberty in inner-city girls. Environ Res 2008; 107: 393-400.

49. Wolff MS, Engel S, Berkowitz G, Teitelbaum S, Siskind J, Barr DB, Wetmur J. Prenatal pesticide and PCB exposures and birth outcomes. Pediatr Res 2007; 61(2):243-50.

50. Wolff MS Landrigan PJ. Environmental estrogens (letter). Science 1994; 266: 525-528.

Phthalates

1. Engel SM, Miodovnik A, Canfield RL, Zhu C, Silva MJ, Calafat AM, Wolff MS. Prenatal phthalate exposure is associated with childhood behavior and executive functioning. Environ Health Perspect 2010; 118(4):565-71.

2. Teitelbaum S, Calafat A, Britton J, Silva M, Wolff M, Reidy J, Brenner B, Galvez M, Ye X. How representative is a single urine sample of a six-moth average for urinary phthalate metabolites and bisphenol A? Epidemiol 2006 2006 November; 17(6):S335-S336.

3. Wolff MS, Engel SM, Berkowitz GS, Ye X, Silva MJ, Zhu C, Wetmur J, Calafat AM. Prenatal phenol and phthalate exposures and birth outcomes. Environ Health Perspect 2008; 116(8):1092-7.

4. Wolff MS, Teitelbaum SL, Pinney SM, Windham G, Liao L, Biro F, Kushi LH, Erdmann C, Hiatt RA, Rybak ME, Calafat AM, Breast Cancer and Environment Research Centers. Investigation of relationships between urinary biomarkers of phytoestrogens, phthalates, and phenols and pubertal stages in girls. Environ Health Perspective 2010.

5. Wolff MS, Teitelbaum SL, Windham G, Pinney SM, Britton JA, Chelimo C, Godbold J, Biro F, Kushi LH, Pfeiffer CM, Calafat AM. Pilot study of urinary biomarkers of phytoestrogens, phthalates, and phenols in girls. Environ Health Perspect 2007; 115(1):116-21.

Polychlorinated Biphenyls

1. Adamu M, Morland K, Golden A, Godbold J, Moshier E, Wolff M, Landrigan PJ. Body burden of pollutants from fish consumption (abstract). In: Proceedings of the 2003 Annual Meeting of the Society of Epidemiologic Research. Am J Epidemiol 2003; 157: 5085.

2. Baker EL Jr, Landrigan PJ, Glueck CJ, Zack MM Jr, Liddle JA, Burse VW, Housworth WJ, Needham LL. Metabolic consequences of exposure to polychlorinated biphenyls (PCB) in sewage sludge. Am J Epidemiol 1980;112: 553-563.

3. Baker EL, Landrigan PJ, Glueck CJ, Zack MM, Liddle JA, Burse VW. Metabolic consequences on population exposure to polychlorinated biphenyls. Clin Res 1978; 26: 657A.

4. Bienenfeld LA, Golden AL, Garland EJ. Consumption of fish from polluted waters by WIC participants in East Harlem. J Urban Health 2003; 80(2):849-858.

5. Engel LS, Laden F, Andersen A, Strickland PT, Blair A, Needham LL, Barr DB, Wolff MS, Helzlsouer K, Hunter DJ, Lan Q, Cantor KP, Comstock GW, Brock JW, Bush D, Hoover RN, Rothman N. Polychlorinated biphenyl levels in peripheral blood and non-hodgkin lymphoma: A report from three cohorts. Cancer Res 2007; 67: 5545-5552.

6. Engel SM, Berkowitz GS, Barr DB, Teitelbaum SL, Siskind J, Meisel SJ, Wetmur JG, Wolff MS. Prenatal organophosphate metabolite and organochlorine levels and performance on the brazelton neonatal behavioral assessment scale in a multiethnic pregnancy cohort. Am J Epidemiol 2007; 165 (12):1397-404.

7. Lamb MR, Taylor S, Liu X, Wolff MS, Borrell L, Matte TD, Susser ES, Factor-Litvak P. Prenatal exposure to polychlorinated biphenyls and postnatal growth: A structural analysis. Environ Health Perspect 2006; 114: 779-785.

8. Landrigan PJ. Developmental neurotoxicity of industrial chemicals and pediatric bipolar disorder: A call to research. In: S. Olfman, editor. Bipolar Children. Praeger Publishers; 2007.

9. Landrigan PJ. PCB cleanup must begin now (letter). The Journal News August 2, 2001.

10. Landrigan PJ. Pesticides, PCBs, and the risk to children. Contemporary Pediatrics 2001; 18(2):110-126.

11. Landrigan PJ. The uses of epidemiology in the study of neurotoxic pollutants - lessons from the workplace. Int J Mental Health 1985; 14: 44-63.

12. Landrigan PJ. General population exposure to environmental concentrations of halogenated biphenyls. In: Kimbrough RD, editor. Halogenated Biphenyls, Terphenyls, Napthalenes, Dibenzodioxins, and Related Products. Amsterdam: Elsevier; 1980.

13. Landrigan PJ, Etzel R. Chemical pollutants. In: Behrman R, editor. Nelson Textbook of Pediatrics. 16th ed. Philadelphia: WB Saunders Co; 1998.

14. Landrigan PJ, Golden A, Berkowitz G, Wolff M, Godbold J. Body burdens of persistent pollutants in Hudson River anglers. Global Forum for Children's Environmental Health; 7-11 September 2001; 2001.

15. Landrigan PJ. Pesticides and polychlorinated biphenyls (PCBs): An analysis of the evidence that they impair children's neurobehavioral development. Molecular Genetics and Metabolism 2001; 73:11-17.

16. Landrigan PJ, Golden AL. Hudson River bass pose danger to fetuses. The Journal News, 2001.

17. Landrigan PJ, Golden AL, Simpson HJ. Toxic substances and their impacts on human health in the Hudson River watershed. In: Levinton J, Waldman J, editors. The Hudson River Estuary. Cambridge University Press; 2006.

18. Morland K, Wolff M, Bopp R, Godbold J, Landrigan PJ. Fish consumption and body burden of organochlorines among lower Hudson urban anglers. Am J Ind Med 2008; 51: 587-594.

19. Nicholson WJ, Landrigan PJ. Human health effects of polychlorinated biphenyls. In: Schecter A, editor. Dioxins and Health. New York: Plenum Publishing Corp; 1994.

20. Seegal RF, Fitzgerald EF, Hills EA, Wolff MS, Haase RF, Todd AC, Parsons P, Molho ES, Higgins DS, Factor SA, Marek KL, Seibyl JP, Jennings DL, McCaffrey RJ. Estimating the half-lives of PCB congeners in former capacitor workers measured over a 28-year interval. J Expo Sci Environ Epidemiol 2010; Journal of Exposure Science and Environmental Epidemiology advance online publication.

21. Seegal RF, Marek KL, Seibyl JP, Jennings DL, Molho ES, Higgins DS, Factor SA, Fitzgerald EF, Hills EA, Korrick SA, Wolff MS, Haase RF, Todd AC, Parsons P, McCaffrey RJ. Occupational exposure to PCBs reduces striatal dopamine transporter densities only in women: A beta-CIT imaging study. Neurobiol Dis 2010; 38(2): 219-225.

22. Wolff MS, Anderson HA, Britton JA, Rothman N. Pharmacokinetic variability and modern Epidemiology-The example of dichlorodiphenyltrichloroethane, body mass index, and birth cohort. Cancer Epidemiol Biomarkers Prev 2007; 16: 1925-1930.

23. Wolff MS, Britton JA, Boguski L, Hochman S, Maloney N, Serra N, Liu Z, Berkowitz G, Larson S, Forman J. Environmental exposures and puberty in inner-city girls. Environ Res 2008; 107: 393-400.

24. Wolff MS, Britton JA, Teitelbaum ST, Eng S, Deych E, Ireland K, Liu Z, Neugut AI, Santella RM, Gammon MD. Improving organochlorine biomarker models for cancer research. Cancer Epidemiol Biomarkers Prev 2005; 14: 2224-2236.

25. Wolff MS, Engel S, Berkowitz G, Teitelbaum S, Siskind J, Barr DB, Wetmur J. Prenatal pesticide and PCB exposures and birth outcomes . Pediatr Res 2007; 61(2): 243-50.

26. Wolff MS, Teitelbaum SL, Lioy PJ, Santella RM, Wang RY, Jones RL, Caldwell KL, Sjödin A, Turner WE, Li W, Georgopoulos P, Berkowitz GS. Exposures among pregnant women near the World Trade Center site on 11 September 2001. Environ Health Perspect 2005; 113(6): 739-748.

Polycyclic Aromatic Hydrocarbons

1. Beyea J, Hatch M, Stellman SD, Santella RM, Teitelbaum SL, Prokopczyk B, Camann D, Gammon MD. Validation and calibration of a model used to reconstruct historical exposure to polycyclic aromatic hydrocarbons for use in epidemiologic studies. Environ Health Perspect 2006; 114(7):1053-8.

2. Herbert R, Marcus M, Wolff M, Perera F, Andrews L, Godbold J, Rivera M, Stefanidis M, Lu Q-X, Landrigan PJ, Santella R. Detection of DNA adducts in white blood cells of roofers by P-postlabeling:Relationship of adduct levels to measures of polycyclic aromatic hydrocarbon exposure. Scand J Work Environ Health 1990; 16: 135-143.

3. Landrigan PJ. Principles for application of porphyrin markers in epidemiological studies. Ann NY Acad Sci 1987; 514: 323-326.

4. Landrigan PJ, Golden AL, Markowitz SB. Occupational cancer in New York City firefighters. New York: United Firefighters Association and United Fire Officers Association; 1994.

5. Mordukhovich I, Rossner P Jr, Terry MB, Santella R, Zhang YJ, Hibshoosh H, Memeo L, Mansukhani M, Long CM, Garbowski G, Agrawal M, Gaudet MM, Steck SE, Sagiv SK, Eng SM, Teitelbaum SL, Neugut AI, Conway-Dorsey K, Gammon MD. Associations between polycyclic aromatic hydrocarbon-related exposures and p53 mutations in breast tumors. Environ Health Perspect 2010; 118(4): 511-518.

6. Shantakumar S, Gammon MD, Eng SM, Sagiv SK, Gaudet MM, Teitelbaum SL, Britton JA, Terry MB, Paykin A, Young TL, Wang LW, Wang Q, Stellman SD, Beyea J, Hatch M, Camann D, Prokopczyk B, Kabat GC, Levin B, Neugut AI, Santella RM. Residential environmental exposures and other characteristics associated with detectable PAH-DNA adducts in peripheral mononuclear cells in a population-based sample of adult females. J Expo Anal Environ Epidemiol 2005; 15(6): 482-490.

7. Shen J, Gammon MD, Terry MB, Wang L, Wang Q, Zhang F, Teitelbaum SL, Eng SM, Sagiv SK, Gaudet MM, Neugut AI, Santella RM. Polymorphisms in XRCC1 modify the association between polycyclic aromatic hydrocarbon-DNA adducts, cigarette smoking, dietary antioxidants, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2005; 14(2): 336-342.

8. Wolff MS, Herbert R, Marcus M, Rivera M, Landrigan PJ, Andrews LR. Polycyclic aromatic hydrocarbon (PAH) residues on skin in relation to air levels among roofers. Arch Environ Health 1989; 44: 157-163.

9. Wolff MS, Teitelbaum SL, Lioy PJ, Santella RM, Wang RY, Jones RL, Caldwell KL, Sjödin A, Turner WE, Li W, Georgopoulos P, Berkowitz GS. Exposures among pregnant women near the World Trade Center site on 11 September 2001. Environ Health Perspect 2005; 113(6): 739-748.

Polyvinyl Chloride (PVC)

1. Froneberg B, Johnson PL, Landrigan PJ. Respiratory illness caused by overheating of polyvinyl chloride. Br J Ind Med 1982; 39: 239-243.

2. Landrigan PJ. Angiosarcoma of the liver among polyvinyl chloride workers - Kentucky. MMWR 1997; 46: 99-101.

3. Waxweiler RJ, Landrigan PJ, Infante P, Shapiro R. Conference to reevaluate the toxicity of vinyl chloride monomer, polyvinyl chloride and structural analogs. Environ Health Perspect 1981; 41:1.

Pregnancy

1. Belogolovkin V, Engel SM, Ferrara L, Eddleman KA, Stone JL. Does sonographic determination of placental location predict fetal birth weight in diamniotic-dichorionic twins? J Ultrasound Med 2007; 26(2):187-91.

2. Berkowitz GS, Obel J, Deych E, Lapinski R, Godbold J, Liu Z, Landrigan PJ, Wolff MS. Exposure to indoor pesticides during pregnancy in a multiethnic, urban cohort. Environ Health Perspect 2003; 111: 79-84.

3. Engel SA, Erichsen HC, Savitz DA, Thorp J, Chanock SJ, Olshan AF. Risk of spontaneous preterm birth is associated with common proinflammatory cytokine polymorphisms. Epidemiology 2005 July 2005; 16(4):469 - 477.

4. Engel SA, Olshan AF, Savitz DA, Thorp J, Erichsen HC, Chanock SJ. Risk of small-for-gestational age is associated with common anti-inflammatory cytokine polymorphisms. Epidemiology 2005 July 2005; 16(4):478 - 486.

5. Engel SM, Berkowitz GS, Barr DB, Teitelbaum SL, Siskind J, Meisel SJ, Wetmur JG, Wolff MS. Prenatal organophosphate metabolite and organochlorine levels and performance on the brazelton neonatal behavioral assessment scale in a multiethnic pregnancy cohort. Am J Epidemiol 2007; 165(12):1397-404.

6. Engel SM, Berkowitz GS, Wolff MS, Yehuda R. Psychological trauma associated with the World Trade Center attacks and its effect on pregnancy outcome. Paediatr Perinat Epidemiol 2005; 19: 334-341.

7. Engel SM, Janevic T, Stein CR, Savitz DA. Maternal smoking, preeclampsia, and infant health outcomes in New York City. Am J Epidemiol 2009; 169(1):22-40.

8. Engel SM, Levy B, Liu Z, Kaplan D, Wolff MS. Xenobiotic phenols in early pregnancy amniotic fluid. Reprod Toxicol 2006; 21: 110-112.

9. Engel SM, Olshan AF, Siega-Riz AM, Savitz DA, Chanock SJ. Polymorphisms in folate metabolizing genes and risk for spontaneous preterm and small-for-gestational age birth. Am J Obstet Gynecol 2006; 195(5):1231.

10. Erichsen HC, Engel SA, Eck PK, Welch R, Yeager M, Levine M, Siega-Riz AM, Olshan AF, Chanock SJ. Genetic variation in the sodium-dependent vitamin C transporters, SLC23A1, and SLC23A2 and risk for preterm delivery. Am J Epidemiol 2006 2006; 163: 245-54.

11. Grandjean P, Bellinger D, Bergman A, Cordier S, Davey-Smith G, Eskenazi B, Gee D, Gray K, Hanson M, van den Hazel P, Heindel JJ, Heinzow B, Hertz-Picciotto I, Hu H, Huang TT, Jensen TK, Landrigan PJ, McMillen IC, Murata K, Ritz B, Schoeters G, Skakkebaek NE, Skerfving S, Weihe P. The faroes statement: Human health effects of developmental exposure to chemicals in our environment. Basic Clin Pharmacol Toxicol 2008; 102: 73-75.

12. Janevic T, Savitz DA, Stein CR, Kaufman JS, Marshall S, Herring AH. Neighborhood deprivation and birth outcome among nine ethnic groups in New York City, 1998 - 2002. The 21st annual meeting of the Society for Pediatric and Perinatal epidemiologic research; June 23-24; 2008.

13. Janevic T, Stein CR, Savitz DA, Kaufman DS, Mason SM, Herring AH. Neighborhood deprivation and adverse birth outcomes among diverse ethnic groups. Ann Epidemiol 2010;20(6):445-451.

14. Landrigan PJ, Wolfe S, Oakley GP Jr. Bad policy, worse medicine. Pediatrics 2000;106:1482-1483.

15. Landrigan PJ, Forman J, Galvez MP, Newman B, Engel SM, Chemtob C. Impact of September 11 World Trade Center disaster on children and pregnant women. Mount Sinai J Med 2008;75:129.

16. Landrigan PJ, Golden AL. Hudson River bass pose danger to fetuses. The Journal News.

17. Marcus M, McChesney R, Golden A, Landrigan PJ. Video display terminals and miscarriages. Journal of the Ameruican Women's Medical Association 2000; 55: 84-88.

18. McChesney R, Marcus M, O'Connor JF, Golden A, Landrigan PJ. The determination of early pregnancy loss using measurement of human chorionic gonadotropin (hCG) - related forms with a modified urine specimen collection protocol. Am J Epidemiol 2000; 151: S49.

19. Savitz DA, Janevic T, Engel SM, Stein CR, Kaufman JS, Herring AH. Pregnancy complications and birth outcomes among Asian Americans in New York City. 21st annual meeting of the Society for Pediatric and Perinatal Epidemiologic Research; June 23-24; 2008.

20. Savitz DA, Stein CR, Dougan M. Serum PFOA and PFOS and pregnancy outcome. The 21st annual meeting of the International Society for Environmental Epidemiology; August 25-29; 2009.

21. Savitz DA, Stein CR, Siega-Riz AM, Herring AH. Gestational weight gain and birth outcome in relation to pre-pregnancy body mass index and ethnicity. Ann Epidemiol 2010.

22. Savitz DA, Stein CR, Siega-Riz AM, Herring AH. Gestational weight gain and pregnancy outcome in New York City, 1995-2003. The 22nd annual meeting of the Society for Pediatric and Perinatal Epidemiologic Research; June 22-23; 2009.

23. Stein CR. Epidemiology of reproductive and developmental health effects of PFAAs. PFAA days III, Environmental Protection Agency; June 8-10; 2010.

24. Stein CR, Chen J, Diplas AI, Lambertini L, Calafat A, Ye X, Teitelbaum SE, Wetmur J, Wolff MS, Sperling R, Lee M, Engel SM. Prenatal phenol exposure and expression of imprinted genes in human placenta. The 22nd annual meeting of the Society for Pediatric and Perinatal Epidemiologic Research; June 22-23; 2009.

25. Stein CR, Ellis JA, Savitz DA, Vichinsky L, Perl SB. Decline in smoking during pregnancy in New York City, 1995-2005. Public Health Rep 2009; 24(6):841-849.

26. Stein CR, Ellis JA, Savitz DA, Vichinsky L, Perl SB. Tobacco use during pregnancy and New York City's tobacco control program, 1995-2005. The 41 st annual meeting of the Society for Epidemiologic Research; June 24-27.

27. Stein CR, Savitz DA. The authors reply re: Serum levels of perfluorooctanoic acid and perfluorooctane sulfonate and pregnancy outcome . Am J Epidemiol 2010; 171(1):132-133.

28. Stein CR, Savitz DA, Dougan M. Serum levels of perfluorooctanoic acid and perfluorooctane sulfonate and pregnancy outcome. Am J Epidemiol 2009; 170(7):837-846.

29. Stein CR, Savitz DA, Janevic T, Ananth CV, Kaufman JS, Herring AH, Engel SM. Maternal ethnic ancestry and adverse perinatal outcomes in New York City. Am J Obstet Gynecol 2009; 6: 584.

30. Stein CR, Savitz DA, Janevic TM, Ananth CV, Kaufman JS, Herring AH, Engel SM. Ethnicity and birth outcome in New York City, 1995-2003. The 21 st annual meeting of the society for pediatric and perinatal epidemiologic research; June 23 - 24; 2008.

31. Terry MB, Perrin M, Salafia CM, Zhang FF, Neugut AI, Teitelbaum SL, Britton J, Gammon MD. Preeclampsia, pregnancy-related hypertension, and breast cancer risk. Am Am J Epidemiol 2007; 165(9):1007-14.

32. Torres-Sánchez L, Rothenberg SJ, Schnaas L, Cebrián ME, Osorio E, Del Carmen Hernández M, García-Hernández RM, Del Rio-Garcia C, Wolff MS, López-Carrillo L. In utero p,p'-DDE exposure and infant neurodevelopment: A perinatal cohort in Mexico. Environ Health Perspect 2007; 115: 435-539.

33. Trasande L, Lee M, Liu Y, Weitzman M, Savitz D. Incremental charges, costs, and length of stay associated with obesity as a secondary diagnosis among pregnant women. Med Care 2009; 47(10):1046-1052.

34. Wolff MS, Engel S, Berkowitz G, Teitelbaum S, Siskind J, Barr DB, Wetmur J. Prenatal pesticide and PCB exposures and birth outcomes. Pediatr Res 2007; 61(2):243-50.

35. Wolff MS, Engel SM, Berkowitz GS, Ye X, Silva MJ, Zhu C, Wetmur J, Calafat AM. Prenatal phenol and phthalate exposures and birth outcomes. Environ Health Perspect 2008; 116(8):1092-7.

36. Yehuda R, Engel SM, Brand SR, Seckl J, Marcus SM, Berkowitz GS. Transgenerational effects of posttraumatic stress disorder in babies of mothers exposed to the World Trade Center attacks during pregnancy. J Clin Endocrinol Metab 2005; 90(7):4115-8.

Propane

1. Landrigan PJ, Melius JM, Rosenberg MJ, Coye MJ, Binkin NJ. Reproductive hazards in the workplace: Development of epidemiologic research. Scand J Environ Health 1983; 9: 83-88.

Public Policy

1. Boardman B, Greaves I, Levenstein C, Landrigan PJ. The pattern of White House budget office decisions in environmental health research. A statistical analysis: Report to subcommittee on oversight and investigations, committee on energy and commerce, U.S. House of Representatives and to the American Public Health Association; 1986.

2. Brandt-Rauf PW, Landrigan PJ. Budget cuts are grave to NIOSH. Am J Ind Med 1995; 28: 457-458.

3. Landrigan PJ. A year of passage. Am J Ind Med 2000; 38: 483-484.

4. Landrigan PJ. Environmental pollution and health. Lancet 1992; 340:1220.

5. Landrigan PJ. Housing and health: Conclusions and challenges for the future. Bull NY Acad Med 1990; 66: 587-591.

6. Landrigan PJ, Harrington JM, Elliott LK. The biotechnology industry. In: Harrington JM, editor. Recent advances in Occupational Health. London: Churchill, Livingstone; 1984.

7. Landrigan PJ MS. The case for OSHA reform (guest editorial). New Solutions 1992; 3: 3-7.

8. Landrigan PJ. MMT, déjà vu and national security. Am J Ind Med 2001; 39: 434-435.

9. Solomon AJ, Doucette JT, Garland E, McGinn T. Healthcare and the long haul: Long distance truck drivers--a medically underserved population. Am J Ind Med 2004; 46(5):463-471.

10. Trasande L. Review: A second opinion: Rescuing America's healthcare. JAMA 2007; 298: 1338.

Radiation

1. Landrigan PJ. Occupational leukemia. State of the Art Reviews 1987; 2:179-188.

2. Landrigan PJ. Recent advances in the assessment of workplace exposure - epidemiologic linkage of medical and environmental data . J Environ Sci Health 1982; A17: 499-513.

3. Landrigan PJ. Overview of industrial chemical exposures. Environ Res 1993; 61: 157-163.

4. Landrigan PJ, Campbell CC. Chemical and physical agents. In: Sweet AY, Brown EG, editors. Fetal and Neonatal Effects of Maternal Disease. St. Louis: Mosby Year Book; 1991.

5. Rinsky RA, Landrigan PJ. Data on lung cancer in radiation workers. Proc Royal Soc Med 1983; 76: 324-325.

Radon

1. Jackson RJ, DiLiberti JH, Landrigan PJ, Nathenson G, Needleman HL, Brown AK, Etzel RA, Falk H, Miller RW, Rogan W. American Academy of Pediatrics, committee on environmental hazards: Radon exposure: A hazard to children. Pediatrics 1989; 83: 799-802.

Sexually Transmitted Disease (STDs)

1. Krain A, Wisnivesky JP, Garland E, McGinn T. Prevalence of human immunodeficiency virus testing in patients with hepatitis B and C infection. Mayo Clin Proc 2004;79(1):51-56.

2. Landrigan PJ, Carter CD, Modlin FJ, Henderson RH, Edwards PQ. Infectious disease in adolescence. In: Ralph I. Lopez, editor. Adolescent Medicine Topics. New York: Spectrum Publications; 1976.

3. Landrigan PJ, Huber DH, Murphy GD 3rd, Creech WB, Bryan JA. The protective effecacy of immune serum globulin in hepatitis A: A statistical approach. JAMA 1973;223:74-75.

4. Mulherin SA, O'Brien TR, Ioannidis JP, Goedert JJ, Buchbinder SP, Coutinho RA, Jamieson BD, Meyer L, Michael NL, Pantaleo G, Rizzardi GP, Schuitemaker H, Sheppard HW, Theodorou ID, Vlahov D, Rosenberg PS. Effects of CCR5-Delta32 and CCR2-64I alleles on HIV-1 disease progression: The protection varies with duration of infection. AIDS 2005 Jul; 17(3):377-87.

5. Pettifor AE, Levandowski BA, MacPhail C, Ford C, Miller WC, Stein CR, Rees H, Cohen M. Rethinking sexual risk behaviors of adolescents in Africa: A comparison of US and South African youth. The 14th annual conference on retroviruses and opportunistic infections; February 25-28.

6. Stein CR, Kaufman JS, Ford CA, Feldblum PJ, Leone PA, Miller WC. Partner age difference and prevalence of chlamydial infection among young adult women. Sex Transm Dis 2008; 35(5):447-452.

7. Stein CR, Kaufman JS, Ford CA, Leone PA, Feldblum PJ, Miller WC. Screening young adults for prevalent chlamydial infection in community settings. Ann Epidemiol 2008; 18(7):560-571.

8. Miller WC Stein CR. Community-based selective screening guidelines for chlamydial infection in young American women. The 25th annual meeting of the American college of epidemiology; September 15 - 18; 2007.

9. Miller WC Stein CR. Community-based selective screening guidelines for chlamydial infection in young American women. The 7th annual women's health research day; April 5, 2006; 2006.

Smoking

1. Engel SM, Janevic T, Stein CR, Savitz DA. Maternal smoking, preeclampsia, and infant health outcomes in New York City. Am J Epidemiol 2009; 169(1):22-40.

2. Engel SM, Janevic TM, Stein CR, Savitz DA. Maternal smoking, preeclampsia, and infant health outcomes in New York City, 1995-2003. Am J Epidemiol 2008; 169(1):33-40.

3. Landrigan PJ, Campbell CC. Chemical and physical agents. In: Sweet AY, Brown EG, editors. Fetal and Neonatal Effects of Maternal Disease. St. Louis: Mosby Year Book; 1991.

4. Landrigan PJ, Cherniack MG, Lewis FA, Catlett LR, Hornung RW. Silicosis in a grey iron foundry: The persistence of an ancient disease . Scand J Work Environ Health 1986; 12: 32-39.

5. Sagiv SK, Gaudet MM, Eng SM, Abrahamson PE, Shantakumar S, Teitelbaum SL, Britton JA, Bell P, Thomas JA, Neugut AI, Santella RM, Gammon MD. Active and passive cigarette smoke and breast cancer survival. Ann Epidemiol 2007; 17(5):385-93.

6. Shen J, Gammon MD, Terry MB, Wang L, Wang Q, Zhang F, Teitelbaum SL, Eng SM, Sagiv SK, Gaudet MM, Neugut AI, Santella RM. Polymorphisms in XRCC1 modify the association between polycyclic aromatic hydrocarbon-DNA adducts, cigarette smoking, dietary antioxidants, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2005; 14(2):336-342.

7. Shen J, Terry MB, Gammon MD, Gaudet MM, Teitelbaum SL, Eng SM, Sagiv SK, Neugut AI, Santella RM. MGMT genotype modulates the associations between cigarette smoking, dietary antioxidants and breast cancer risk. Carcinogenesis 2005; 26(12):2131-2137.

8. Stein CR, Ellis JA, Savitz DA, Vichinsky L, Perl SB. Decline in smoking during pregnancy in New York City, 1995-2005. Public Health Rep 2009; 24(6):841-849.

9. Stein CR, Ellis JA, Savitz DA, Vichinsky L, Perl SB. Tobacco use during pregnancy and New York City's tobacco control program, 1995-2005. The 41 st annual meeting of the society for epidemiologic research; June 24 - 27.

Solvents

1. Baker EL Jr, Smith TJ, Landrigan PJ. The neurotoxicity of industrial solvents: A review of the literature. Am J Ind Med 1985; 8: 207-217.

2. Landrigan PJ, Goyer RA, Clarkson TW, Sandler DP, Smith JH, Thun MJ, Weeden RP. The work-relatedness of renal disease. Arch Environ Health 1984; 39: 225-230.

3. Morawetz JS, Landrigan PJ. A cluster of traumatic occupational deaths at a foundry, 1974-1986. MMWR 1989; 38: 293-297.

Vaccinations

1. Grand M, Wyll S, Gehlbach S, Landrigan PJ, Judelsohn R, Zendel S, Witte J. Clinical reactions following rubella vaccination: A prospective anaylsis of joint, muscular, and neuritic symptoms. JAMA 1972; 220: 1569-1572.

2. Landrigan PJ. Can measles vaccine cause hearing loss? JAMA 1973; 219:92.

3. Landrigan PJ, Murphy KB, Meyer HM Jr, Parkman PD, Eddins DL, Witte JJ. Combined measles-rubella vaccines: Virus dose and serologic response. Am J Dis Child 1973; 125:65-67.

4. Landrigan PJ, Rivas EN, Eddins DL. Epidemiologic assessment of a nationwide multiple antigen vaccine campaign. J Trop Pediatr 1974; 20: 135-140.

5. Landrigan PJ, Stoffels MA, Anderson E, Witte JJ. Epidemic rubella in adolescent boys. clinical features and results of vaccination. JAMA 1974; 227:126-129.

6. Landrigan PJ, Witte JJ. Neurologic disorders following live measles-virus vaccination. JAMA 1973; 223: 1459-1462.

7. Landrigan PJ. Epidemic measles in a divided city. JAMA 1972; 221: 567-570.

8. Marshall R, Habicht JP, Landrigan PJ, Foege WH, Delgado H. Effectiveness of measles vaccine given simultaneously with DTP. J Trop Pediatr 1974; 20: 135-140.

9. Wallace RB, Landrigan PJ, Smith EA, Pifer J, Teller B, Foster SO. Trial of a reduced dose of measles vaccine in nigerian children. Bull WHO 1976; 53: 361-364.

Water and Soil Contaminants

1. Forman J, Satlin L, Amler RW, Winston JA, Fleissner ML, Toal B, Landrigan PJ. Environmental uranium contamination of well water associated with beta-2-microblobulinuria. Global Forum for Children's Environmental Health; 7-11 September 2001.

2. Landrigan PJ. Exposure to dimethylmercury. New Engl J Med 1998; 339: 1243-1244.

3. Landrigan PJ. Occupational and community exposures to toxic metals - lead, cadmium, mercury and arsenic. Western J Med 1982; 137: 532-539.

4. Landrigan PJ. Overview of industrial chemical exposures. Environ Res 1993; 61: 157-163.

5. Landrigan PJ, Baker EL. Exposure of children to heavy metals from smelters: Epidemiology and toxic consequences. Environ Res 1981; 25: 204-244.

6. Landrigan PJ, Bridbord K. Additional exposure routes. In: Dahlem Konferenzen, editor. Changing Metal Cycles and Health. Berlin: Springer-Verlag; 1984.

7. Landrigan PJ, Gross RL. Chemical wastes - illegal hazards and legal remedies. Am J Public Health 1981; 71: 985-987.

8. Tornheim JA, Morland KB, Landrigan PJ, Cifuentes E. Water privatization, water source, and pediatric diarrhea in bolivia: Epidemiologic analysis of a social experiment. Int J Ocupp Environ Health 2009; 15: 241-248.

World Trade Center

1. Berkowitz GS, Wolff MS, Janevic TM, Holzman IR, Yehuda R, Landrigan PJ. The World Trade Center disaster and intrauterine growth restriction. JAMA 2003; 290: 595-596.

2. Boscarino JA, Adams RE, Foa EB, Landrigan PJ. A propensity score analysis of brief worksite crisis interventions after the World Trade Center disaster: Implications for intervention and research. Med Care 2005; 44: 454-462.

3. Brand SR, Engel SM, Canfield RL, Yehuda R. The effect of maternal PTSD following in utero trauma exposure on behavior and temperament in the 9-month-old infant. Ann NY Acad Sci 2006; 1071: 454-8.

4. Chemtob CM, Conroy DL, Hochauser CJ, Laraque D, Banks J, Schmeidler J, Dela Cruz M, Nelsen WC, Landrigan PJ. Children who lost a parent as a result of the terrorist attacks of September 11, 2001: Registry construction and population description. Dealth Studies 2007; 31: 87-100.

5. Claudio L, Garg A, Landrigan PJ. Addressing environmental health issues. In: Sidel V. Levy B, editor. Terrorism and Public Health. New York: Oxford University Press; 2002.

6. Engel SM, Berkowitz GS, Wolff MS, Yehuda R. Psychological trauma associated with the World Trade Center attacks and its effect on pregnancy outcome. Paediatr Perinat Epidemiol 2005; 19: 334-341.

7. Galvez MP, Peters R, Graber N, Forman J. Effective risk communication in children's environmental health: Lessons learned from 9/11. Pediatr Clin North Am 2007; 54(1):33-46.

8. Herbert R, Moline J, Skloot G, Metzger K, Baron S, Luft B, Markowitz S, Udasin I, Harrison D, Stein D, Todd A, Enright P, Stellman JM, Landrigan PJ, Levin SM. The World Trade Center disaster and the health of workers: Five-year assessment of a unique medical screening program. Environ Health Perspect 2006; 114: 1853-1858.

9. Landrigan PJ, Garg A. Public health: What's next? The Green Guide 2002; 90: 4.

10. Landrigan PJ. The WTC disaster: Landrigan's response. Environ Health Perspect 2004; 112: A607.

11. Landrigan PJ. Lessons learned: Worker health and safety since September 11, 2001. Am J Ind Med 2002; 42: 530.

12. Landrigan PJ. Strong chemicals, strong action, strong control. The CHEC Report 2002(8).

13. Landrigan PJ. Confronting the health consequences of the World Trade Center attacks. 130th Annual meeting of the environment; 9-13 November 2002.

14. Landrigan PJ. Health consequences of the September 11 attacks. (editorial) Environ Health Perspect 2001; 109: A514-A515.

15. Landrigan PJ, Lioy PJ, Thurston G, Berkowitz G, Chen LC, Chillrud SN, Gavett SH, Georgopoulos PG, Geyh AS, Levin S, Perera F, Rappaport SM, Small C, NIEHS World Trade Center Working Group. Health and environmental consequences of the World Trade Center disaster. Environ Health Perspect 2004; 112: 731-739.

16. Landrigan PJ, Forman J, Galvez M, Newman B, Engel SM, Chemtob C. Impact of September 11 World Trade Center disaster on children and pregnant women. Mount Sinai J Med 2008; 75: 129.

17. Moline JM, Herbert R, Crowley L, Troy K, Hodgman E, Shukla G, Udasin I, Luft B, Wallenstein S, Landrigan PJ, Savitz DA. Multiple myeloma in World Trade Center responders: A case series. JOEM 2009; 51(8):896-902.

18. Moline JM, Herbert R, Levin S, Stein D, Luft BJ, Udasin IG, Landrigan PJ. WTC medical monitoring and treatment program: Comprehensive health care response in aftermath of disaster. Mount Sinai J Med 2008; 75: 67-75.

19. Stellman JM, Smith RP, Katz CL, Sharma V, Charney DS, Herbert R, Moline J, Luft BJ, Markowitz S, Udasin I, Harrison D, Baron S, Landrigan PJ, Levin SM, Southwick S. Enduring mental health morbidity and social function impairment in World Trade Center rescue, recovery, and cleanup workers: The psychological dimension of an environmental health disaster. Environ Health Perspect 2008; 116(9):1248-1253.

20. Wolff MS, Teitelbaum SL, Lioy PJ, Santella RM, Wang RY, Jones RL, Caldwell KL, Sjödin A, Turner WE, Li W, Georgopoulos P, Berkowitz GS. Exposures among pregnant women near the World Trade Center site on 11 September 2001. Environ Health Perspect 2005; 113(6):739-748.

21. Yehuda R, Engel SM, Brand SR, Seckl J, Marcus SM, Berkowitz GS. Transgenerational effects of posttraumatic stress disorder in babies of mothers exposed to the World Trade Center attacks during pregnancy. J Clin Endocrinol Metab 2005; 90(7):4115-8.